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Abstract 
The femoro-popliteal (FP) segment is the most commonly diseased artery of the peripheral 
circulation. Obstructions of these lower-limb arteries are frequent and even with the new 
generation Nitinol stents (drug-eluting or otherwise), long-term restenosis rates following 
endovascular procedures range from 15 to 40% and are much higher compared with the long-
term outcomes after coronary artery interventions.  
The major difference between peripheral and coronary arteries concerns their mechanical 
environments, with the FP arterial segments being subjected to repeated external 
deformations during leg flexion. It has been widely hypothesized that the high distortion of 
the tissues due to the un-physiological deformations of the arteries following stent 
implantation is the main cause for restenosis. However, there is very limited information on 
the FP artery deformations of patients with Peripheral Arterial Disease (PAD). Furthermore, 
the effects of endovascular therapy on the deformation behavior of the PAD-afflicted FP 
arteries are currently unknown. As such, further research on the deformations of the FP 
arteries is warranted to not only improve existing stent designs, but to also determine the 
correct interventional procedure. 
The main objectives of this thesis were to characterize the deformation behavior and 
mechanical response of the FP arterial tract through clinical and numerical investigations. The 
former was achieved by, first, investigating the pre-angioplasty deformations of the FP arteries 
during leg flexion in a pilot study of five patients with PAD and utilizing 3D rotational 
angiography. The methodology was then adapted to perform a clinical study of 35 patients 
with PAD, in which X-ray angiography was used to image the FP arteries in straight and flexed 
positions prior to endovascular therapy and following either Percutaneous Transluminal 
Angioplasty (PTA) or primary Nitinol stent implantation. The 3D models of the FP arteries were 
reconstructed from the 2D X-ray angiograms and the deformations of axial deformation and 
  
curvature were quantified. Both studies showed that the PAD-afflicted FP arterial segment 
undergoes significant shortening and an increase in curvature with leg flexion. Comparisons 
between the pre- and post-treatment deformations, as well as between the different 
treatment methods, suggested that the choice of the treatment method significantly affects 
the post-interventional axial deformations of the FP arteries (post-balloon: 7.6% ± 4.9%; post-
stent: 3.2% ± 2.9%; P: 0.004). As such, while PTA results in a more flexible artery, stents restrict 
the arteries’ shortening capabilities. Depending on the anatomical position of the stents, this 
axial stiffening of the arteries may lead to chronic kinking, which may cause occlusions and, 
consequently, impact the long-term success of the procedure. As current stent designs were 
found to conform to the curvature behavior of the FP arterial tract, improvements should be 
focused on reproducing the native axial stiffness of the artery to reduce the risk of restenosis 
for patients that will have to undergo stent implantation.  
The complexities caused by leg flexion are further exacerbated by controversial clinical 
practices, such as Nitinol stent oversizing. The procedure is frequently performed in peripheral 
arteries to ensure a desirable acute lumen gain and strong wall apposition, and to prevent 
stent migration. However, the increased radial force exerted onto the arterial walls by the 
oversized stents could lead to significant arterial damage and, in turn, restenosis. The 
contradictory findings between animal and clinical studies, in conjunction with the majority of 
the numerical studies focusing on balloon-expandable stents, suggests that the efficacy of the 
procedure remains as an issue to be answered. 
The mechanical behavior of the FP artery under Nitinol stent oversizing was investigated by 
creating a validated finite element (FE) framework, which included numerical models of 
healthy FP arteries with patient-specific geometries and idealized arteries with clinically 
relevant levels of PAD. Based on the artery model, either only stent implantation or the 
complete endovascular therapy (PTA + stent implantation) was simulated. Four different 
stent-to-artery ratios ranging from 1.0 to 1.8 were used in the simulations. For the healthy 
arteries, additional analyses, in the form of computational fluid dynamics (CFD) analyses and 
fatigue behavior of the stents, were performed to observe the hemodynamic behavior of the 
arteries with respect to increased oversizing ratios. For the calcified arteries, three different 
plaque types were modeled to report the influence of the plaque behaviors on the outcomes 
of endovascular therapy and stent oversizing. Regardless of the presence of a plaque tissue, 
results showed that Nitinol stent oversizing was found to produce a marginal lumen gain in 
 ix 
contrast to a significant increase in arterial stresses. For the lightly and moderately calcified 
arteries, oversizing was found to be non-critical; whereas for healthy and heavily calcified 
arteries, the procedure should be avoided due to a risk of tissue failure. These adverse effects 
to both the artery walls and stents may create circumstances for restenosis. Although the ideal 
oversizing ratio is stent-specific, the studies showed that Nitinol stent oversizing has a very 
small impact on the immediate lumen gain, which contradicts the clinical motivations of the 
procedure.  
In order to predict the possibility of restenosis through mechanical markers that are 
associated with the effects of leg movement following stent implantation, clinical 
investigations should be complimented with patient-specific numerical analyses. Combining 
intra-arterial imaging methodologies with in-vivo arterial deformations, which can be 
translated to FE simulations as boundary conditions, and building upon the numerical 
framework that is introduced in the 2nd part of this thesis, it’s possible to generate accurate 
patient-specific models. These models, evaluated in conjunction with clinical follow-ups, are 
expected to provide a deeper understanding of the mechanical background of restenosis in 
peripheral arteries.  
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Chapter 1 
Introduction 
 
1.1 Clinical Background 
Obstructions of the femoro-popliteal arteries in the lower limbs of the body – clinically 
commonly manifested as peripheral arterial disease (PAD) – is mainly caused by 
atherosclerosis.47 The disease is estimated to be present in 3% of people in the age range of 
40 - 59 years and in 20% of people over 70 years of age.89 In addition, between the years 2000 
and 2010, a 23.5% increase in worldwide PAD incidence has been reported.39 The introduction 
of balloon angioplasty, a mechanical widening of an obstructed artery through a small arterial 
puncture hole, has made this method the foremost in the treatment of PAD ever since its 
introduction over three decades ago.89 Its major advantages over surgical revascularization 
are related to its minimal-invasiveness. However, endovascular therapy for femoro-popliteal 
(FP) arterial obstructions may be associated with a very high frequency of disease recurrence 
due to restenosis. Restenosis, a re-narrowing of the artery post angioplasty, may be caused 
by arterial elastic recoil79, negative arterial remodeling113 and neointimal hyperplasia102 and 
remains the Achilles’ heel of this minimally-invasive treatment approach.  
The placement of stents into widened arteries to relieve blockages and act as mechanical 
scaffoldings has been an effective treatment method since its inception.47,89 While stent 
implantation has largely insured high success rates for coronary arteries59,80,84,134, it could not 
overcome the issue of restenosis in peripheral arteries. With the implantation of balloon-
expendable stents, patency rates dropped to levels obtained with performing only 
percutaneous transluminal angioplasty (PTA) after only six months or one year.7,10,48  
Therefore, more flexible stents have been developed for the peripheral arteries. These self-
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expendable Nitinol stents improved the clinical outcomes and showed an increase in the rates 
of primary patency and freedom from target lesion revascularization (TLR) compared to 
previous approaches.30,68,74,115 However, restenosis still remains a significant problem in the 
peripheral arteries with clinically significant restenosis occurring in about one third of the 
patients undergoing placement of bare metal Nitinol stents.106 While the introduction of drug-
eluting Nitinol stents helped further solve the issues caused by non-coated stents, the long-
term restenosis rates of 17% (from controlled clinical trials) and an even worse real-world 
outcome of 37% suggest that the problems caused directly by this mechanically challenging 
anatomical region continue to persist.27,28,33,58,103,115 Recently, drug-coated balloons have been 
proposed as an alternative to stent implantation altogether.103 The long-term outcomes of the 
initial reports seem to favor this “leave-nothing-behind” approach with restenosis rates of 
17%125 and 19%132 comparing favorably with the outcomes from drug-eluting stents. 
However, limited number of clinical trials and contradictory outcomes among different 
devices99,125,132 suggest that the technology needs further advancements before it can be 
considered the gold standard among the available endovascular treatments. Furthermore, 
bail-out stenting will continue to be utilized for cases, in which the PTA results in suboptimal 
revascularization. Therefore, there is a need to improve the long-term outcomes of stent 
implantation in FP arteries. 
1.2 Causes for Restenosis 
A number of clinical and numerical studies analyzed the causes for in-stent restenosis in FP 
arteries31,35–37,65,82,105,109,118. Due to the flexion of the knee, the FP artery is constantly 
subjected to mechanical deformations caused by the physiological activities of the patients. 
As a consequence, the Superficial Femoral Artery (SFA) and the popliteal artery are submitted 
to significant shortening, elongation, torsion, flexion, and vulnerability to external 
compression. 
1.2.1 Stent Fractures 
It has been proposed that stent fractures are caused by this complex biomechanical 
environment of the arterial tract. These deformations were reported to reduce the fatigue life 
of the stents implanted in these lower-limb arteries.4,6,37,41,57,65,86,88,92,118 Iida et al. analyzed 
the effect of exercise on stent fractures by performing follow-up studies on 40 patients, who 
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underwent Nitinol stent placement.57 While the lesion length, region and level of calcification 
and the number of implanted stents all influenced the fracture rates, the amount of exercise 
was found to be the main motivator for stent fractures. Babalik and colleagues reported the 
results of a case report, in which a patient with high grade stenosis in the left popliteal artery 
was implanted with 2 overlapping self-expandable stents.6 Stent fractures were found to have 
occurred 6 months after implantation due to flexion of the knee joint. Via single-case studies, 
Kröger et al. investigated the effect of leg movement on both balloon and self-expandable 
stents and linked the stent failures with leg flexions.65 Solis et al. presented a single case study, 
in which a patient, who had a severe background of Peripheral Vascular Disease (PVD), was 
implanted with a self-expandable stent around a high flexion point.118 After only 4 months, a 
resultant stent fracture had led to the formation of a pseudo aneurysm. Based on these 
observations, these single-case studies6,65,118, as well as some major multi-center trials105,109, 
suggested a link between stent fractures and in-stent restenosis or reduced patency of the 
stented segment.  
Despite the studies that suggested a correlation between stent fractures and restenosis, this 
hypothesis was in question from the start.9,33,127 Analyzing the 1-year outcome of the 
DURABILITY I trial, in which 151 patients with varying levels of PAD were implanted with 
PROTÉGÉ Everflex stents, Bosiers and co-workers reported a fracture rate of 8.1%.9 70% of 
these cases, which included 40% of the severe fracture category, showed no restenosis. The 
results of the SIROCCO trial, in which 93 patients were implanted with either drug-eluting or 
bare SMART stents, displayed a fracture rate of 22% at a 2-year follow-up.33 The relation 
between the stent fractures and in-stent restenosis was not clearly reported; however, it was 
noted that all but one of the fracture cases were clinically asymptomatic. The theory that stent 
fractures lead to in-stent restenosis has also been refuted by recent clinical studies performed 
with new generation of stents. These studies report that stent fracture rates have decreased 
to only a few percent133, while long-term clinical outcomes continue to remain 
poor.27,28,72,104,133 
1.2.2 Arterial Deformations 
Another possible cause for in-stent restenosis is the trauma to the inner or outer layers of the 
artery induced by its interaction with the rigid Nitinol stent. The combined effect of the arterial 
deformations during motion of the leg and the difference in mechanical stiffness between the 
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stent and the arterial wall is reported to produce harsh contact conditions between stents and 
tissues. In turn, these repeated mechanical interactions could lead to acute and chronic 
irritation of arterial walls, which may trigger restenosis.36,86,96 Furthermore, changes in the 
mechanical environment following stent implantation might lead to kinking of the native FP 
arterial segment, either distal or proximal to the stented regions.4,86  
Clinical Investigations 
Arena reported severe edge dissections at the proximal and distal ends of the Nitinol stents 
implanted in 2 patients with different clinical backgrounds.3,4 In both cases, the motion of the 
SFA and the popliteal arteries led to unnatural, even flow-limiting kinking in the immediate 
unstented segments, which became worse with recurrent leg flexions (Fig. 1.1). This extreme 
deformation behavior may lead to further arterial re-obstructions, including complete 
occlusions of the FP segment, and to repeat revascularizations shortly after the primary 
endovascular operation. Consequently, it is reasonable to assume that the complex 
biomechanical properties of the femoro-popliteal arterial tract play a crucial role in the re-
obstruction of the arteries subsequent to endovascular therapy. 
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Figure 1.1. Following the implantation of a single, long Nitinol stent along the FP artery, the 
bending of the leg results in an extreme deformation (i.e. kinking) at the non-stented popliteal 
artery adjacent to the distal end of the stent (Image taken from Arena3). 
To date, the flexion behavior of the FP arterial tract is only very poorly understood. While it is 
clear that the FP arterial segment is exposed to a variety of biomechanical strains during knee 
flexion, the behavior of this segment post placement of Nitinol stents is complex. Several in-
vivo studies have been conducted to evaluate the arterial deformations due to the motion of 
the leg.16,17,31,40,44,46,63,87 Cheng et al. performed contrast medium-enhanced magnetic 
resonance (MR) imaging on both legs of 8 human subjects (mean age ± SD: 27 ± 5 y) with no 
PAD.17 The SFAs were imaged with patients in supine and fetal positions and the analyzed 
segments were isolated to the iliofemoral arteries between the profunda femoris and 
descending genicular arteries. For both legs, significant shortening and twisting of the SFAs 
were observed as the patients moved to fetal positions. In an effort to investigate the effect 
of age on arterial deformations, Cheng and colleagues redid the same study on 7 older, healthy 
human subjects (mean age ± SD: 56 ± 5 y).16 While the imaging protocol and the investigated 
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arterial segments correlated with the previous study, the condition for the leg motion was 
changed to a slightly lesser knee/hip flexion of 90º/40º to better conform to the patients’ 
ages. As with the previous study, the arteries shortened in length and twisted due to the 
flexion; however, the values for these deformation metrics were lower in older patients, 
suggesting a less-compliant artery with increased age. Furthermore there was significant 
bending observed in the arteries of older patients, which was associated with the reduced 
slack towards axial shortening. Nikanorov et al. estimated the arterial deformations prior to 
and following stent implantation into the SFAs of 8 cadavers, which underwent lateral 
radiograph imaging in straight, walking and sitting positions.88 Klein and coworkers 
constructed 3D models of the FP arteries of 10 patients (mean age ± SD: 57 ± 10.2 y), who 
underwent angiographic imaging in straight and crossed leg positions.63 The patients were 
diagnosed with PAD, but the study group was limited in the sense that they either had mild or 
no calcifications. The measured arterial deformations compared well with other studies, as 
the results showed significant arterial shortening, twisting and bending as the leg moved from 
straight to crossed leg position. While the above-mentioned studies made important 
contributions to the small, but ever-expanding field of in-vivo estimation of peripheral arterial 
deformations, the investigated subjects did not represent the patient population that 
undergoes endovascular therapy of the lower-limbs.   
Recent studies tried to overcome these limitations by performing these measurements in 
patients with clinically relevant PAD and with patients implanted with stents. Nikanorov and 
colleagues performed lateral radiographs on 17 patients, none of whom had severe 
calcifications.87 The patients were implanted with 23 Absolute (Abbott Vascular, Santa Clara, 
CA, USA) self-expandable Nitinol stents and the images were taken in leg positions used in 
their cadaver study.88 The measurements, estimated from the 2D images, showed that the 
amount of bending and shortening in the popliteal artery was more critical than the SFA and 
that the chronic leg movement had limited impact on the arterial deformations in the long-
term. The major limitation of this work was in the methodology. By performing the 
measurements on single 2D radiographs, the authors have overlooked the three-dimensional 
nature of the arterial deformations, which may introduce inaccuracies to their findings. Finally, 
Ganguly et al. utilized a C-arm computed tomography system to acquire the images of the 
lower-limbs of 13 human subjects that had stents.40 The images were taken with the legs in 
straight and flexed positions. They used an in-house semi-automatic image analysis software 
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to measure the compression, twisting and bending of the investigated segments and, similar 
to the previous studies, reported a shortening in the lengths and an increase in the curvatures 
of the stents. However, the limited information concerning the flexion angle, stent types and 
lesion locations makes it difficult to accurately interpret their results.  
Following implantation, stents are expected to locally modify the stiffness of the artery, which 
will lead to a concentration of deformations in the unstented arterial sections.4 The 
deformations of these bare arteries in the close vicinity of the stented segments are currently 
unknown. Repetition of these non-physiological large deformations could increase the risk of 
restenosis through chronic arterial damage and abnormal blood flow conditions. This 
observation raises another research question concerning the appropriate stenting procedure 
in the regions subjected to large deformations. A couple of clinical studies suggested that 
stents that are implanted in the close proximity of the high curvature areas lead to the 
aforementioned kinking phenomena4,112. These clinical observations question current 
paradigm of spot stenting (i.e. covering only the atherosclerotically diseased part of the artery) 
for the obstructions in the high curvature areas of the FP intersection. An alternative approach 
would be to use longer stents that cover the majority of these high-risk areas, which is 
expected to produce a smoother deformation of the artery and avoid kinking. Currently, no 
study has investigated the deformation behavior of the high curvature areas when implanted 
with long stents. A comparison between spot-stenting vs. long stenting may give further 
insight into the ideal stenting approach to decrease restenosis rates.  
Numerical Studies 
In addition to the local deformations of the lower extremities, the loads acting on the arteries 
will induce additional damage to the arterial walls. During flexion of the leg, increased 
compression and shear forces will be exerted onto the stent, leading to increased stresses in 
the arteries and higher shear stresses at the stent/artery interface. These increased loads have 
been proposed to increase the damage to the arterial walls.36,86,129 However, information on 
the mechanical environment at the level of the stent/artery interface cannot be accessed 
clinically. Therefore, numerical models that enable the analyses of local stent-artery 
interactions are needed.  
Numerical tools, finite element (FE) and computational fluid dynamics (CFD) analyses have 
been widely used to analyze stent design34,77,124, stent-artery5,66,76,123, stent-balloon81,131 and 
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stent-graft interactions64, as well as structural stress distributions in different layers of the 
artery, hemodynamical properties along the lumen surface and fatigue performance of stents 
under different loading conditions.32,75,76,91,131,135 However, the majority of the existing studies 
were focused on the coronary arteries and only a handful of studies were concerned with 
peripheral artery deformations. 
Early et al. performed various numerical analyses concerning the deformations of stented 
peripheral arteries.35–37 They proposed FE analyses on the deployment of balloon-expandable 
and Nitinol stents in peripheral arteries and calculated the stress distribution in the tissue 
walls following the application of a bending boundary condition onto the artery.37 Their results 
suggested that arterial bending could be the primary cause of high restenosis rates observed 
in the FP arterial tract. In a following study, they used FE modeling to investigate the effects 
of the mechanical environment of peripheral arteries on Nitinol stents through bending and 
compression simulations.36 Their results implied that the different arterial segments (SFA and 
popliteal artery) along the complete FP arterial tract behave differently towards bending and 
compression and location specific stents should be used in FP arteries to avoid restenosis. 
However, both studies were limited as they used idealized artery models with a simple 
mechanical behavior and the boundary conditions they applied were not an accurate 
representation of the biomechanical environment of the FP arteries.  
Diehm et al. developed patient-specific FE models from magnetic resonance angiography 
(MRA) images of the lower limbs, in both extended and flexed positions, to simulate the 
bending of the knee.31 Their aim was to observe the mechanical environment of the FP artery 
during this flexion. Although their FE model is interesting, no implants were considered in this 
work. In addition, this study only focused on healthy patients and the amount of bending 
considered was relatively small when compared to other studies. In two very recent studies, 
Ghriallais and Bruzzi proposed a FE framework, which includes models of arteries, muscles 
and bones, to model leg flexion and investigate the deformations and stress/strain 
characteristics of both healthy and pseudo-stented arteries.85,86 Their results showed that the 
mechanical environment of the stented arteries change drastically compared to the healthy 
arteries and allude to arterial buckling around the ends of the stented region based on stress 
concentrations. The study, however, is limited by the lack of an actual stent model as the 
stented regions were created by solely changing the stiffness of the arteries. As a result, the 
deployment procedure and the complex contact interactions between the stent and the artery 
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walls were completely overlooked. Furthermore, the proposed approach has not been 
validated.  
A few other teams also studied the effect of the mechanical loading following stent 
implantation in peripheral arteries.32,49,75,82,91,96 Müller-Hülsbeck et al. used FE analysis to 
investigate the strain distribution and, consequently, the fatigue failure of different Nitinol 
stents under bending, compression and torsion in the SFA. While the work provided 
interesting findings concerning the strain characteristics for different stent types, the loading 
conditions used in this work were based on an ex-vivo setting and only included the stent itself 
without an artery model.82 Similarly, Harvey compared two stent designs submitted to basic 
loading conditions and pulsatile blood pressure.49 In a numerical study, Rebelo et al. 96 studied 
the effect of blood flow on the fatigue behavior of the stent, but neglected the mechanical 
effects of the arterial deformations.  Dordoni et al. have used FE models to analyze the effects 
of arterial deformations following PTA and primary stent implantation of arteries with 
different plaque geometries.32 Petrini et al. have developed a tool to apply patient-specific 
arterial shortening during leg flexion to an idealized arterial model with the intention to detect 
possible stent fractures.91 However, these models only focused on the deformation of the 
stent and its fatigue behavior. Furthermore, the process of balloon angioplasty, which is a 
mandatory step prior to Nitinol stent deployment, have been completely overlooked by most 
of these studies35–37,49,96. On the other hand, when the procedure was included in the analyses, 
the resultant lesion configuration following balloon expansion have not been verified as there 
is a lack of information on the mechanical behavior of the plaque under the loads inflicted 
during endovascular therapy. As such, the simplifications adopted towards the plaque 
behavior, such as using a perfect plasticity or stress softening model for plaque failure, 
possibly limit the accuracy of the results. 
1.2.3 Nitinol Stent Oversizing 
The desired outcome of any endovascular procedure is to have a satisfactory lumen gain and 
sustain it in the long-term. For cases where clinicians suspect a possibility of lumen narrowing 
following PTA, stents are deployed to act as an internal scaffold. However, the decision to 
implant a stent, as well as the stent’s size, is not defined by any objective criteria and mostly 
relies on the expertise of the clinicians. The necessity to implant a stent can be determined 
based on the severity of the calcification and the amount of elastic recoil following PTA. On 
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the other hand, stent sizing remains a delicate matter; its consequences not only showing 
differences between different anatomical regions93,101,137, but also within the same 
arteries.11,61  
Clinical Investigations 
Stent sizing is defined as the ratio of unconstrained stent diameter to non-calcified lumen 
diameter. For the cases, in which this ratio is below 1.0, the stent is deemed to be undersized. 
On the other, if this ratio above 1.0, the stent is considered to be oversized. 
In clinical practice, choosing a nominal stent diameter that is 1 mm larger than the artery 
diameter has been suggested.101 However, this limit is frequently exceeded in order to 
establish an optimal wall contact with the artery61, avoid stent mallapposition93 and prevent 
stent migration.121 Despite these seeming advantages, excessive radial forces exerted by the 
oversized stents and an overstretching of the artery walls can create the circumstances for 
arterial damage, neointimal/adventitial hyperplasia and, ultimately, restenosis.  
Both clinical and numerical studies on Nitinol stent oversizing in peripheral arteries are 
scarce.20,43,45,101,130,136,137 Therefore, in order to have a better understanding of the subject 
matter and show the conflicting results of the clinical studies, this review also includes some 
notable works on self-expandable stent oversizing in carotid arteries.11,61,93  
Regardless of the anatomical location, the majority of the studies have been performed on 
healthy animals. Zhao et al. implanted 28 Nitinol stents into 14 Yucatan swine.137 Stents were 
implanted in pairs into the left or right iliofemoral arteries and overlapped each other. The 
oversizing ratio ranged from 1.2-1.9 and a threshold from normal-sizing to oversizing was set 
as 1.4. Based on this limit, 8 of the swine were normal-sized and 6 were oversized. At a 6 
month follow-up, it was found the luminal area stenosis increased linearly with increased 
oversizing. Furthermore, exceeding the aforementioned threshold resulted in the 
overstretching of the artery walls that led to arterial damage, neointimal proliferation (NIP) 
and luminal area stenosis (Fig. 1.2). The study concluded with a recommended oversizing ratio 
between 1.1 and 1.4. Saguner and coworkers deployed 10 uncoated and 6 Tinox-coated 
Nitinol stents in 6 mini-pigs.101 4 pigs got 3 stents (left and right external iliac artery; and either 
left or right SFA); while 2 pigs got 2 stents (left and right external iliac artery). Based on Zhao’s 
work, the normal-to-oversized stent threshold was taken as 1.4. The follow-up study was 5 
months later. Out of 16 stents, 21 segments were recovered; among these, 12 were normal-
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sized and 9 were oversized. The clinical outcome was similar to the previous study, with 
increased NIP and in-stent restenosis being observed with increased oversizing and above the 
threshold of 1.4. Tinox-coating did not yield a better outcome.  
  
Figure 1.2. The angiographic (l1, m1 & h1) and histology images (l2, m2, h2 & l3, m3, h3) of 
the iliofemoral arteries of Yucatan swine stented with different oversizing ratios show that 
increased oversizing (> 1.6) leads to extensive damage to the artery walls, increased 
neointimal hyperplaisia and, consequently, restenosis (Image taken from Zhao et al.137).  
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Cho et al. implanted a total of 6 Nitinol stents into 6 beagles.20 In each case, the stents covered 
the abdominal aorta and the right external iliac artery. This resulted in a varying oversizing 
ratio along the length of the stented segment with the average values being 1.2 and 2.0 for 
the aortas and iliac arteries, respectively. At a 3 month follow-up, the amount of NIP was 
significantly higher in the oversized iliac arteries compared to the aortas. Zamora and 
colleagues deployed a total of 12 self-expanding stents (Wallstent) in common iliac veins of 6 
mini-pigs and divided the subjects into 3 oversizing groups of 119% to 152%; 153% to 186%; 
and 187% to 220%.136 At a 3 month follow-up, all subjects showed neointimal hyperplasia and 
lumen loss; however, a statistically significant increase in in-stent restenosis due to stent 
oversizing was only observed for the cases with the oversizing ratio above 153%. Finally, a very 
early study by Vorwerk et al. approaches the subject not through stent oversizing, but by 
implanting  two different types of Wallstents with different radial forces into the femoral 
arteries of 15 FP arteries of 10 dogs.130 In contrast to the previously reported studies, it was 
found that the amount of NIP at 6 months was the same for both stents and that a lower radial 
force did not mean lower tissue formation. 
In order to make a comparison between 4 different stent types, Cha et al. implanted a total of 
22 self-expandable stents in both common carotid arteries of 9 canines.11 The resultant 
oversizing ratios ranged from 1.2 to 1.5. A follow-up at 6 months showed that there was a 
significant average late lumen loss in 3 of the stent groups, with complete occlusion being 
observed in the remaining group. Furthermore, stents that resulted in higher initial lumen 
gains led to higher amounts of neointimal hyperplasia. Kirsch et al. deployed a total of 24 
Nitinol stents, which included 3 different stent types, in 6 greyhound dogs.61 Each dog were 
implanted with 4 stents; 2 in the right and 2 in the left common carotid arteries. While the 
distally implanted stents were normal-sized with oversizing ratios that ranged from 1.2-1.4; 
the proximally implanted stents were over-sized with ratios of 2.0-2.5. Contrary to the 
previous work, the amount of neointimal hyperplasia was found to be the same for both 
oversized and normal-sized stents. Moreover, all stents had low neointimal response. Finally, 
Piamsomboon and colleagues have implanted 63 self-expanding stents (Wallstent) in 59 
human patients, who had more than 60% stenoses in their internal carotid arteries.93 The 
oversizing ratio for all stents were between 1.4 to more than 2.0. The calcifications were 
cracked and stents were post-dilated. At a follow-up of 6 months, it was found that oversizing 
did not lead to late restenosis; moreover, late lumen loss was lower with increased oversizing. 
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This last study is especially relevant considering it’s the only one that is performed on human 
patients and with clinically relevant stenosis levels. 
Numerical Studies 
The small number of clinical studies, the inter-variability between stents, species and the 
arterial segments within said studies and a lack of clinical investigations performed on human 
subjects warrant further research into this controversial clinical phenomenon. Numerical 
models can easily be implemented in order to have a better description of the biomechanical 
implications of oversizing on arterial tissues. However, not only the number of studies that 
were concerned with stent oversizing are limited, but they focused on the deployment of 
balloon-expandable stents in idealized models of healthy13,15,66 and calcified14,128 coronary 
arteries. 
The most notable work on the subject was conducted by Chen and colleagues.13–15 By utilizing 
CFD and structural FE analyses, they have performed simulations of balloon-expandable stent 
implantation in idealized, non-calcified coronary arteries and investigated the effects of both 
stent undersizing and oversizing.13 They found that while a small amount of undersizing (5%) 
resulted in worse outcomes concerning Wall Shear Stress (WSS), Wall Shear Stress Gradient 
(WSSG) and Oscillatory Shear Index (OSI), 20% undersizing produced results similar to 0% 
undersizing. On the other hand, increased oversizing was reported to lead to increased 
circumferential wall stresses. They followed this work by performing an animal study (in 
conjunction with additional CFD and FE simulations), in which they implanted the coronary 
arteries of 10 swine with both undersized (10%) and oversized (10%, 20% and 30%) balloon-
expandable stents.15 Comparing the results from numerical analyses with the extent of 
damage and neointimal hyperplaisia observed 4 weeks after implantation, they reported 
findings similar to their previous work and concluded that stent missizing may lead to 
restenosis through adverse effects on the hemodynamical behavior of the arteries and 
increased wall stresses. However, the experiments were not used to model the arteries and, 
as such, they cannot be seen as a direct validation of the numerical models.  Additionally, 
neither of the studies included the plaque tissue, which is necessary to represent the target 
demographic that undergoes stent implantation. In order to overcome this limitation, the 
same group introduced a simplified calcification to their numerical models to investigate the 
effects of balloon-expandable stent missizing on diseased arteries.14 The results were similar 
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to their previous works, as they reported a decrease in low WSS and increases in WSSG, OSI 
and wall stresses with increased oversizing. However, their results were limited as they neither 
simulated balloon angioplasty nor any kind of failure mechanism for the plaque, which is a 
crucial and necessary step performed during a routine endovascular therapy.  
Although not directly investigating the concept of stent oversizing, there are additional studies 
which have suggested that an increased circumferential deformation of the artery leads to a 
decrease in the WSS and higher circumferential wall stresses, both of which have been linked 
with restenosis.66,128 However, none of these studies are directly adaptable to the 
endovascular procedures performed in lower-limbs due to the differences in stent types, 
deployment techniques (i.e. balloon-expandable vs. self-expandable) and artery, as well as 
atherosclerotic plaque, models. Furthermore, they do not represent the common clinical 
practice due to the use of healthy arterial models and the exclusion of PTA.
1.3 Thesis Objectives 
Within the last two decades, the number, as well as the scope, of both clinical and numerical 
studies concerning FP artery deformations and FP artery stenting has substantially increased. 
The primary aims of these studies were to improve current stent designs, establish ideal stent 
implantation methods and reduce restenosis rates that have been negatively affecting the 
long-term outcomes of endovascular procedures performed on the FP arteries. However, with 
the majority of the works being conducted on subjects that do not represent the population 
targeted for endovascular therapy of the FP arteries, the results can only give limited 
information on the FP artery deformations. Currently, the deformation behavior of the FP 
arteries with PAD and the effects of Nitinol stent implantation on the deformations of said 
arteries are only partially understood. Furthermore, there is no reported data regarding the 
influence of plain old balloon angioplasty (POBA) on the deformations of the FP arteries 
diagnosed with PAD. Therefore, the first objective of this thesis was to:  
To quantify the in-vivo deformations of the popliteal arterial segment during leg flexion in 
subjects with clinically relevant (Fontaine Stage IIb) PAD. 
Five patients with varying calcification levels of the popliteal arterial segment underwent 3D 
rotational angiography during endovascular revascularization. Image acquisition was 
performed with the leg straight and with a flexion of 70°/20° in the knee/hip joint. The arterial 
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centerline and the corresponding branches in both positions were segmented to create 3D 
reconstructions of the arterial trees. Axial deformation, twisting, and curvatures were 
quantified. Furthermore, the relationships between the calcification levels and the 
deformations were investigated. This pilot study is covered in Chapter 2. 
Following the establishment of the methods necessary to quantify the deformations of the FP 
artery, utilizing them on a pilot study and comparing the values with previous studies to 
evaluate the accuracy of the process, the second objective of the thesis was defined as:  
Quantifying the deformations of the FP arteries in patients undergoing endovascular 
revascularization and comparing the effects of primary Nitinol stent implantation on the 
post-treatment arterial deformations with the effects of percutaneous transluminal 
angioplasty (PTA). 
35 patients with peripheral arterial disease (PAD) were recruited for the study. During 
endovascular interventions, angiographic images were acquired with the legs straight and 
with a hip/knee flexion of 20°/70°. Image acquisition was performed before PTA for all 
patients; after PTA for 17 patients that only underwent balloon angioplasty; and after primary 
Nitinol stent implantation for the remaining 18 patients. A semi-automatic approach was used 
to reconstruct the 3D patient-specific artery models from 2D radiographs. Axial shortening and 
curvature changes in the arteries were calculated in-vivo for the calcified, ballooned and 
stented regions, as well as the regions that are distal and proximal to the diseased and treated 
segments. This part is presented in Chapter 3. 
In addition to these objectives to further understand the pre- and post-operative 
deformations of the FP arteries, another important aim of the thesis was to build an FE 
framework to investigate the controversial procedure of Nitinol stent oversizing. The 
contradictory findings between animal and clinical studies, in conjunction with the majority of 
the numerical studies focusing on balloon-expandable stents, suggests that the efficacy of the 
procedure remains questionable. Furthermore, there are no studies on the effects of gradual 
Nitinol stent oversizing on the mechanical behaviors of the FP arteries with clinically relevant 
levels of PAD. In order to address these issues, the following objectives were defined. 
To investigate the structural and hemodynamic effects of Nitinol stent oversizing in 
geometrically patient-specific FE and CFD models of FP arteries. 
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The anatomies of the FP arteries of five patients from the pilot study were adopted for the 
analyses. 3D FE models were reconstructed with a lumen diameter of 5 mm and the fiber-
induced material model represented a healthy popliteal artery. Deployment simulations of two 
different Nitinol stents, with diameters ranging from 5.5 to 9 mm, were performed. Arterial 
stresses, luminal gains and fatigue behavior of one stent were analyzed. Furthermore, CFD 
analyses were used to simulate the physiological blood flow inside the stented arteries to 
obtain WSS parameters. Chapter 4 deals with this part.  
To study the effects of Nitinol stent oversizing using FE analyses of endovascular therapy of 
a FP artery model with a clinically relevant level of PAD. 
Finite element analyses of endovascular revascularization of an idealized artery with 70% 
stenosis and three different plaque types have been performed to examine the influence of 
Nitinol stent oversizing on the arterial stresses and acute lumen gain. The analyses included 
the simulation of balloon angioplasty to model plaque failure, followed by stent implantation, 
in which four different oversizing ratios were investigated. This final objective is discussed in 
Chapter 5. 
Each of the chapters is either published (Chapters 2 & 4), accepted for publication (Chapter 3) 
or submitted for publication (Chapter 5). As such, they are presented in this thesis as they 
have been published, with small adjustments made to some of the methodology sections to 
better explain the concepts behind each study. 
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Chapter 2 
In-vivo Deformations of the Popliteal 
Artery during Leg Flexion in Subjects 
with Peripheral Arterial Disease44 
 
2.1. Introduction 
The obstruction of lower limb arteries, commonly known as peripheral arterial disease (PAD) 
is mainly caused by atherosclerosis.47,89 Endovascular therapy is currently considered the 
primary treatment modality for many PAD patients.89 Restenosis,79,102,113 a narrowing of the 
dilated artery subsequent to endovascular therapy, hampers clinical outcomes following 
balloon angioplasty of the femoro-popliteal (FP) arterial segment in up to 60% of the patients 
at one year.106 Although the introduction of novel Nitinol stents decreased restenosis rates 
compared to plain balloon angioplasty (POBA),108 restenosis still remains a significant problem 
in peripheral arteries.84,106 In-stent restenosis occurs in up to 30% of the patients subsequent 
to bare metal Nitinol stent placement106 and was reported to be associated with stent 
fractures65,118 and arterial wall damage.69,113 Stent failures are clearly associated with the 
forces exerted on the FP arteries, which are caused by bending, torsion and axial motions 
during hip and knee flexion.16,31,63 Moreover, the effects of this mechanical environment, 
along with different stent designs and material properties, on the stent-artery wall 
interactions lead to arterial wall damage.69 
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To understand the causes of restenosis and improve stent designs, an accurate 
characterization of this mechanical environment is necessary. Due to the difficulties arising 
from in-vivo measurement of mechanical forces, previous studies concerned with this 
characterization focused on the quantification of in-vivo arterial deformations.16,17,21,31,63,88,117 
Although the improvements with each new study are evident, there are certain limitations 
that may affect their results; namely the use of cadavers88,117, young17,31 and healthy 
subjects,16,21 and subjects with only mildly or non-calcified arteries.63 To our knowledge, no 
data is available concerning arterial deformations in patients with clinically relevant PAD. This 
information is critical since these patients correspond to the target group for stenting and 
calcified arteries may deform differently when compared with healthy tissue.  
Aim of the present study is to gain a better understanding of the mechanical environment of 
the atherosclerotically diseased popliteal arterial tract. Based on the above-mentioned 
limitations of previous studies, it is our understanding that quantifying the deformational 
change in mild to severely calcified diseased arteries will give a more realistic insight into the 
mechanical environment created during leg flexion. 
2.2. Materials and Methods 
2.2.1. Patient Selection 
Images were obtained on a clinical indication on five patients (1 female, mean age 71 ± 9) 
during endovascular therapy for femoro-popliteal arterial obstructions. Clinical characteristics 
and risk factors are outlined in Table 2.1. Ethics committee approval for the present study was 
not required since patients were treated according to the regular clinical protocol. In addition, 
all patients signed a general consent form approved by our institutional review board, thereby 
agreeing on usage of anonymized data for quality control and retrospective studies.  
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Table 2.1. Patient demographics, clinical presentation, cardiovascular risk factor profile and 
level of calcification. 
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 
Age 76 56 65 79 69 
Gender Male Male Male Male Female 
Fontaine stage IIb IIb IIb IIb IIb 
Hyperlipidemia  No No Yes Yes No 
Diabetes mellitus  Yes Yes No No Yes 
Arterial Hypertension  Yes Yes Yes Yes Yes 
Cigarette smoking  Yes Yes Yes No Yes 
Coronary heart disease  Yes No No Yes No 
Cerebrovascular disease No No No No No 
Creatinine (mol/l) 78 85 89 75 58 
Level of obstruction Popliteal Popliteal Popliteal Popliteal Popliteal 
Calcification Heavy 
(Level 2) 
None 
(Level 0) 
Moderate 
(Level 1) 
Heavy 
(Level 2) 
Moderate 
(Level 1) 
Stenosis vs. occlusion Stenosis Occlusion Stenosis Stenosis Stenosis 
2.2.2. Image Acquisition 
For each patient, 3D rotational angiography of the popliteal arterial segment was performed 
(AXIOM-Artis, Siemens, Germany) in two natural lower limb positions: with the subjects’ lower 
limb fully extended and during flexion of the knee. 3D rotational angiography was performed 
utilizing a standard commercially available dyna CT algorithm on the angiographic 
workstation. Care was taken to standardize knee flexion in all patients, with the help of a 
specifically designed cast placed under the patients’ legs over which the knees were bent (Fig. 
2.1). The resulting configuration corresponded to a position in normal walking situation with 
a 70°/20° flexion in the knee joint.88 
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Figure 2.1. Positioning of the leg during 3D rotational angiography: Straight (left) and flexed 
(right) with the help of a cast designed to simulate the walking condition. 
All 3D angiographic examinations were saved digitally and transferred to a workstation 
(Microsoft Windows operating system) capable of three-dimensional post-processing to 
quantify the deformation of the arterial tract for each patient. For 4 patients, the investigated 
segment of the arterial tract started from the descending genicular artery and ended at the 
superior genicular artery, while it ended at the inferior genicular artery in one patient. 
Vascular calcification was assessed using a semi-quantitative scoring system: no (0) versus 
moderate (1) versus heavy calcification (2). 
Image Segmentation 
For an accurate quantification of the arterial deformations, the obtained images were first 
subjected to pre-processing. In summary, the patients’ vasculature and bone structures were 
segmented on the 3D image datasets using an image-analysis software (Amira 5.2, 
Visualization Sciences Group SAS). As a result, the 3D vascular tree was obtained for both 
flexion angles of the leg (Fig. 2.2). Based on these three-dimensional reconstructions, 
corresponding arterial branches were identified on the two positions. Four landmarks were 
used to establish the 3D correspondences between the reconstructed arteries at the two 
angles of flexion dividing the artery into three segments that contain two branches each. The 
centerline of the whole artery and its respective segments were extracted with the 
skeletonized feature of Amira. B-splines were used to represent the centerlines, which 
provided parametric representations of the arteries. 
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Figure 2.2. Threshold-based segmentation of the bone and artery for patient #1 with the leg 
in a straight position (left) and after flexion (right). 
2.2.3. Quantification of Arterial Deformations 
The deformations of the arteries during the flexion were quantified with the axial 
deformation, the twist angle and the curvature of the artery. The procedure used in this study 
follows standard techniques previously published,16,21 but will be summarized here.  
Based on the splines describing the arterial centerline, the arc length of the arteries was 
calculated at each flexion angle. The axial deformation was then measured as the change in 
the lengths of the segments between straight and flexed positions, divided by the total length 
of the artery (Fig. 2.3). 
For the twist angle quantifications, the “angle of separation” for each segment was calculated 
by measuring the angle between consecutive side branches. The angle of separation was 
measured before and after flexion; the angular change induced by the motion corresponded 
to the twist angle. In addition, the twist angle rate was calculated by dividing the twist angle 
by the length of the arterial segment. Since the arteries are not straight, the calculations 
required to obtain the angle of separation must consider the curvature of the arteries. This 
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calculation is done by division of the arterial centerlines into very short sections, such that 
each section can be assumed to be lying on a plane. The angle between consecutive sections 
was calculated and used to compensate for the arterial curvature (Fig. 2.3). A detailed 
description of the mathematical derivation can be found elsewhere.21 
 
Figure 2.3. Quantification of deformations on the artery: For axial elongation (left), the 
difference in length of the centerline between the identified landmarks was measured; for 
torsion (middle), the change in orientation of arterial branches was calculated; and for 
curvature (right), the inverse of the radius of the circle, defined by three points on the 
centerline, was calculated. 
The arterial curvature was calculated using the osculating circle along the length of the artery. 
The radius of the circle was defined by three points on the centerline. To avoid measuring 
insignificant local curvatures, these three points were separated by a distance equal to the 
arterial diameter. The curvature was defined as the inverse of the radius of the fitted circles. 
Unlike axial length and twist quantifications, curvatures were calculated along the entire 
length of the arteries and not for each individual segment (Fig. 2.3).
In addition, the relation between the severity of calcification and the deformation metrics 
were analyzed. Spearman’s rank correlation95 (ρ) was utilized as a statistical analysis to assess 
the dependence between these parameters. If an increase in one of the parameters leads to 
either an increase or decrease in the other one, and if this relation can be defined by a 
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monotonic, but not specifically a linear function, Spearman suggests that these parameters 
have a positive or negative correlation. A correlation coefficient of +1 means a perfect positive 
correlation. In this study, the deformation metrics were sorted and ranked in an ascending 
order, as were the patients’ corresponding calcification levels. 
2.3. Results 
Axial length of the popliteal arterial segment decreased during bending of the leg when 
compared to the straight leg position in all patients (Table 2.2). Average compression for all 
patients was found to be 5.9% ± 2.5%; while the average maximum compression was 16.4% ± 
8.4%. Moreover, we observed twisting of the arterial segment during leg flexion: The average 
twist rate was 3.8 º/cm ± 2.3 º/cm, with an average twist angle of 45º ± 25º (in the range of 
6º – 71º). The measurements also showed that both the mean and the maximum curvature 
of the artery increased during flexion of the leg. Arterial twisting was about two times higher 
after flexion of the knee joint when compared to the curvature measured in the straight 
position. 
Table 2.2. Three-dimensional arterial deformations of the popliteal arterial segment during 
knee flexion in five patients undergoing endovascular therapy; axial compression, twist rate 
and curvature. 
 
 Straight to flexed Curvature (cm-1) 
 Axial (%) Twist rate (°/cm) Straight Flexed 
Patient Mean Max Mean Max Mean Max Mean Max 
1 -4.5 -27.4 5.9 13.2 0.09 0.17 0.23 0.39 
2 -7.6 -23.3 5.9 10.9 0.04 0.08 0.08 0.17 
3 -6.6 -9.2 0.5 1.3 0.06 012 0.06 0.2 
4 -8.4 -11.6 4.5 8.5 0.07 0.13 0.14 0.22 
5 -2.4 -10.4 2.2 4.8 0.05 0.08 0.08 0.21 
Mean  
± SD 
-5.9  
± 2.5 
-16.4  
± 8.4 
3.8 
± 2.2 
7.7  
± 4.8 
0.06  
± 0.02 
0.12  
± 0.04 
0.12  
± 0.07 
0.24  
± 0.09 
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The level of calcification increased from mild to severe among the patients considered. A 
strong positive correlation was observed between the maximum curvature and the level of 
arterial calcification, with a ρ factor of 0.97 and 0.98 for straight and flexed positions, 
respectively (Fig. 2.4). The same correlation was observed between the mean arterial 
curvatures and the calcification with a ρ factor of 0.98 for both straight and flexed positions. 
On the other hand, no relationship between the extent of arterial calcification and axial 
compression or arterial twisting was observed (calculated correlation ρ of 0.40 and 0.43, 
respectively). 
 
Figure 2.4. Deformation behaviors of the popliteal arterial segments of five patients with 
respect to different calcification levels for the maximum curvatures (cm-1) in straight (black) 
and flexed (gray) legs. Vascular calcification was assessed using a semi-quantitative scoring 
system: no (0), moderate (1) and heavy (2) calcification.
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2.4. Discussion 
The FP arterial segment is a very challenging territory for endovascular therapy and especially 
for the placement of stents.89,106 Excessive biomechanical deformations may constitute 
possible explanations for the limited success of stents in these arterial segments.16,31,63 To 
provide a deeper understanding about the mechanical environment in popliteal arteries 
during flexion, arterial deformations of five patients with various levels of arterial calcifications 
ranging from mild to severe were quantified based on 3D rotational CT imaging. 
Our results suggest that flexion of the leg in the knee joint induced a decrease of arterial 
length, an increase of the curvature as well as substantial amount of twisting in the popliteal 
arterial segment. Furthermore, an increase in the calcification level led to an increase in the 
maximum curvature observed in both straight and flexed positions, while no change in the 
amount of arterial twisting and axial deformation was observed for the different levels of 
calcification. 
A direct comparison of these results with previous publications is difficult due to the use of 
different methodologies, where healthy volunteers were considered with various mechanical 
configurations and imaging modalities.16,17,21,31,63,88,117 Although these studies provided 
important information concerning arterial deformations occurring during various activities, 
they mostly considered young17,31 and healthy subjects,16,21 and subjects with only mild or 
non-calcified arteries.63 To our knowledge, the present study is the only one on subjects with 
clinically relevant PAD; however, the general arterial behavior during the flexion measured in 
the present work is consistent with previous observations. All published studies reported 
arterial shortening during leg flexion. The mean amount of shortening reported previously 
ranges from 15.1% for patients with mild calcifications63 to 7.4% for healthy subjects16. With 
a 5.9% mean shortening for arteries with moderate to severe calcifications, surements 
showed a slightly lower axial compression. This confirms the decreased elasticity of the artery 
from young, healthy subjects to older diseased patients. Concerning the mean twist angle 
between straight and flexed positions, Klein and coworkers 63 observed a change of 61.1º ± 
31.9º in the popliteal arteries of subjects with mild calcifications.. These findings are on par 
with the mean change of the twist angle of 45.9° ± 25.4° obtained in the present study. Due 
to the differences in the lengths of the arterial tracts, the comparison of the twist rate is more 
important than the mean twist angle. The axial twist rate found in the previous studies was 
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between 1.9 °/cm and  3.46 °/cm for the popliteal arteries of patients with clinically different 
backgrounds.14  These results compare favorably with our calculation of 3.8°/cm ± 2.3°/cm, 
since the amount of deformation applied to the leg was in the lower range of the scale.  
Due to a limited number of studies on curvature, a satisfactory evaluation of the results, with 
regard to their accuracy is challenging. Klein and coworkers 63 quantified the mean curvature 
of the PA segment in straight leg and crossed leg positions as 0.1 cm-1 ± 0.02 cm-1 and  0.31 
cm-1 ± 0.1 cm-1. Cheng’s findings on curvature vary considerably with respect to the subjects. 
While no bending was reported in the popliteal arteries of healthy, young subjects;17 a 
maximum supine curvature of 0.11 cm-1 ± 0.05 cm-1 and a maximum flexed curvature of 0.47 
cm-1 ± 0.24 cm-1 were observed along the proximal popliteal arteries of healthy, old subjects.16 
While both our mean and maximum straight curvatures compare with these results, the mean 
and maximum flexed curvatures of 0.12 cm-1 ± 0.07 cm-1 and 24 cm-1 ± 0.09 cm-1 is lower than 
the reported values. This finding may be attributed to slightly more pronounced knee flexion 
in the compared studies.16,63 
The comparison of our results with the previous studies suggest that, although there are 
significant deformations in the popliteal arteries of diseased patients during leg flexion, the 
amount of change observed in the PAD patients does not differ significantly from the ones 
observed in healthy volunteers.16,17,21 The differences between the published results are likely 
to be attributed to anatomical variations between patients. Based on this observation, we 
may conclude that the level of calcification has a limited effect on both the axial deformation 
and twisting of the popliteal arteries when the leg is flexed. The observed relation between 
the calcification levels and curvature in both leg positions suggests that as the extent of 
calcification increases, the curvature of the PA increases. This is in agreement with the 
observation of Cheng and colleagues16, which attributes the increased curvature to lower 
elasticity of arteries impacted by patient age.
One possible and significant use of these measurements with respect to improving the stent 
designs is in Finite Element (FE) simulations. Since the stents undergo rigorous FE simulations 
during development, these measurements can be applied as boundary conditions to 
realistically model the deformation of calcified arteries, even without explicitly modeling the 
calcification. To our knowledge, the measurements used in the previous FE simulations are all 
based on cadaveric35,36,49 or healthy arteries31 and ignore any possible effect the calcification 
level may have on the deformation metrics, contrary to what we have showed in the present 
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study. The use of these measurements in FE simulations might have a role in improving stent 
designs through the analysis of stent behavior and their fracture mechanics under these 
deformations. 
Several limitations of the present study need to be discussed. First, due to size constraints of 
the angiographic imaging system, we could not consider the entire length of the FP arterial 
segment, but concentrated on its distal part. Moreover, space constraints in the angiographic 
system limited the extent of leg motion. Although the flexed position of the leg considered in 
this study is one of the most important to consider, the procedure could not be extended to 
more complex physiological situations. Future studies should consider 2D X-ray image 
acquisitions, which can cover a larger segment of the artery and also allow for higher flexion 
angles. Although the deformations along the FP arterial segment are not uniform, most of the 
deformation is expected to take place in the target region analyzed. Future studies should also 
consider quantifying the entire FP arterial segment to disregard any effect the sizes of the 
arteries might have on the results. Another limitation concerns the limited number of patients 
included; however, the typical number of subjects in similar work is between 1 and a 
maximum of 10.16,17,21,31,63 In addition, the patients considered in this study covered a large 
range of arterial calcifications, which is sufficient to provide an assessment of the effect of the 
PAD on the arterial deformations. 
2.5. Conclusion 
The study showed that 3D rotational angiography is a method suitable to accurately quantify 
the deformation of the PA segment in patients. The available workspace is larger than other 
3D imaging systems such as MRI, which enables more realistic range of flexion. In addition, it 
provides a full three-dimensional representation of the tissue and is not limited to bi-
dimensional radiographic projections. The measurements were performed on subjects with 
varying levels of arterial obstruction, in both straight and flexed leg positions thereby 
representing knee joint positions as observed during walking. We observed significant changes 
in curvature, twist angle and length of the popliteal arterial segment during leg flexion. The 
quantifications also lead to a relation of a higher curvature with more severe calcification 
levels. This implies that the calcification directly affects the curvature, while no such relation 
with twisting or axial deformation was found. This relation supports the idea that the 
quantifications help to uncover clinically very important information on the deformation 
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mechanics of the lower limb arteries and may give important insight into stent placement and 
design. The methodology followed in this pilot study proved to be appropriate to achieve 
accurate 3D quantifications and can therefore be used to collect data on larger groups of 
patients.
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Chapter 3 
In-vivo Quantification of Femoro-
popliteal Artery Deformations: 
Percutaneous Transluminal Angioplasty 
vs. Nitinol Stent Placement46,112 
 
3.1. Introduction 
For over a decade, endovascular therapy has been the primary treatment method for most 
patients with peripheral arterial disease (PAD).89 The main challenge with this treatment has 
been to overcome comparatively high restenosis rates in the femoro-popliteal (FP) arteries 
and the need for target lesion revascularization (TLR). The implantation of Nitinol stents 
following percutaneous transluminal angioplasty (PTA) using conventional non-coated 
balloons improved restenosis rates,30,67,74,115 but led to a new set of problems such as arterial 
wall damage through stent-artery interactions,36,96,113 loss of primary patency due to 
neointimal hyperplasia or stent fractures,2,65,91 or restriction of the natural deformation 
behavior of the FP arterial tract.4,85 The invention of drug-eluting Nitinol stents, along with 
improved stent designs, partially solved these issues.27,132,133 The remaining occurrences of 
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restenosis are hypothesized to have a mechanical origin and to be caused by the stents’ effects 
on the arterial deformations during leg flexion.4,85  
With the advent of drug-coated balloons, bioresorbable stents and atherectomy devices, the 
state of the art in the endovascular treatment of FP lesions is moving away from stent 
placement and towards the so-called "leave-nothing-behind" strategy.1,103 The motivation 
behind this approach is to completely resolve the problems caused by the presence of 
permanent metal scaffolds. A limited number of non-randomized clinical trials addressed the 
efficacy of this technology and initial results showed superior outcomes than both plain old 
balloon angioplasty (POBA) and non-coated stents, as well as similar primary patency and TLR 
rates compared with drug-coated stents.103,125,132 However, contradictory outcomes among 
different devices suggest that the technology needs further advancements before it can be 
considered the gold standard among the available endovascular treatments.99,125,132 
Furthermore, stent placement will continue to be utilized for cases in which PTA fails to 
provide optimal revascularization. Therefore, there is a need to improve the long-term 
outcomes of stent implantation in FP arteries. To reduce the risk of restenosis, current stent 
designs should be adapted to conform to the dynamic mechanical environment in the FP 
arteries. 
In order to observe whether PTA provides better arterial flexibility compared to stent 
placement, axial deformation and bending behavior of the FP artery following both 
approaches need to be investigated. While several publications reported the in-vivo 
deformations of healthy and calcified arteries in both living subjects and cadavers,16,17,31,44,63,88 
only two studies examined the arterial deformations of patients who underwent stent 
placement.40,87 However, both studies had limitations that impacted the significance and 
interpretation of their results.  The study from Nikanorov et al. only considered a single Nitinol 
stent and the measurements were performed on single 2D radiographs, overlooking the 
three-dimensional nature of the arterial deformations.87 On the other hand, Ganguly et al. 
mainly focused on the methodology and validation behind the deformation analyses, and 
provided limited information concerning the flexion angle, stent types and lesion locations, 
thereby making it difficult to interpret their findings.40 Additionally, the implications of plain 
old balloon angioplasty on the deformation behavior of the FP artery are currently not known. 
Therefore, the objective of this work was to quantify the in-vivo FP artery deformations of 
patients undergoing primary Nitinol stent implantation when compared with PTA alone. In 
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addition, by comparing the post-angioplasty deformation behavior with the deformations 
following stent implantation, current shortcomings of existing stent designs could be 
identified. 
3.2. Materials and Methods 
3.2.1. Data Acquisiton 
This study was approved by the local ethics committee. Each patient also signed a consent 
form to accept inclusion into the study and approve the analysis of acquired data, in 
anonymized form, outside the clinical environment. 35 patients (20 males; mean age: 69 ± 10) 
scheduled for endovascular therapy were recruited to undergo 2D radiographic imaging of 
their lower limbs. All patients were classified with a Fontaine stage of IIB and had a mean 
lesion length of 69 mm ± 9 mm. Information about the anatomical lesion locations, as well as 
the patients’ calcification levels, are presented in Tables 3.1 & 3.2.  
The method of treatment for each patient was decided during endovascular therapy. All 
patients underwent an initial balloon angioplasty, in which the balloon was expanded 
approximately to 10 atmospheres. Based on a qualitative evaluation of lesion behavior and 
arterial recoil, primary stent implantation was deemed necessary for 18 patients. With three 
patients being fitted with two stents, a total of 21 self-expanding Nitinol stents were 
implanted: Six Pulsar 18 (Biotronik AG, Bülach, Switzerland); one Xpert (Abbott Vascular, Santa 
Clara, CA, USA); five Zilver PTX (Cook Medical Inc., Bloomington, IN, USA); and nine EverFlex 
(Ev3 Endovascular Inc., Plymouth, MN, USA) (Table 3.1). Stents were implanted with an 
overlap of approximately 5 mm into the proximal and distal segments of the lesions. Among 
the remaining 17 patients who solely underwent PTA, only two patients were treated with 
drug-coated balloons, and all were subjected to subsequent balloon expansions until an 
adequate lumen diameter was reached (Table 3.2).  
All angiographic images were acquired with a Philips Allura FD 20 Xper X-ray system with 
Clarity Upgrade (Best, Netherlands). Contrast material was diluted by 50% with saline and 
injected over the arterial sheath. Prior to the acquisitions, a lightweight calibration phantom 
was attached to the patients’ thighs using a strap. The initial acquisition was performed before 
treatment in two steps; first with the leg in straight position and then with a knee/hip flexion 
of 70°/20°. Depending on the chosen treatment method, the acquisition was repeated either 
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immediately after PTA or primary stent implantation. At each configuration, a set of two 
images, separated by an average view angle of 45 to 60 degrees, was acquired. The images 
were stored on the workstation in terms of subtraction angiography and cine-images.  
Table 3.1. Patient demographics, level of calcification, as well as the description of the lesions 
and implanted stents in the stent group. 
Patient 
no. 
Age Gender 
Calcification 
level 
Lesion Implanted stents 
Location 
Length 
(mm) 
Type Size 
1 65 M Moderate 
Mid SFA/ 
Distal SFA 
60 Pulsar-18 ∅6 x 40 mm 
2 75 M Moderate 
Distal SFA / 
Popliteal 
180 Pulsar-18 ∅6 x 200 mm 
3 56 M Moderate 
Mid SFA/ 
Distal SFA 
50 Xpert ∅4 x 40 mm 
4 68 F Moderate Mid SFA 60 Zilver PTX ∅5 x 80 mm 
5 66 F 
In-stent 
re-occlusion 
Prox. SFA / 
Mid SFA 
200 EverFlex ∅5 x 150 mm 
6 75 M Severe 
Mid SFA / 
Distal SFA 
180 EverFlex ∅6 x 200 mm 
7 79 F Severe 
Prox. SFA / 
Distal SFA 
350 
Pulsar-18 
(x2) 
∅5 x 200 mm 
8 71 M Severe 
CFA** / 
Distal SFA 
350 
Everflex 
(x2) 
∅6 x 200 mm 
9 66 F Moderate 
Prox. SFA / 
Distal SFA 
300 Pulsar-18 ∅5 x 200 mm 
10 76 F Severe 
Prox. SFA / 
Distal SFA 
400 
Everflex 
(x2) 
∅6 x 200 mm 
11 65 M Moderate Distal SFA 100 Zilver PTX ∅6 x 120 mm 
12 71 M Moderate 
Mid SFA / 
Distal SFA 
100 Zilver PTX ∅6 x 120 mm 
13 81 M Moderate Popliteal 70 Pulsar-18 ∅5 x 80 mm 
14 48 M Severe 
Mid SFA / 
Distal SFA 
50 Everflex ∅6 x 60 mm 
15 79 F Severe Mid SFA 80 Everflex ∅5 x 100 mm 
16 61 M Moderate Mid SFA 100 Zilver PTX ∅5 x 120 mm 
17 62 M Moderate 
Prox. SFA / 
Mid SFA 
300 Everflex ∅6 x 200 mm 
18 65 M Moderate Distal SFA 100 Zilver PTX ∅6 x 120 mm 
Avg ± 
SD 
    
168  ± 
120 
 
168 mm± 
131 mm 
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Table 3.2. Patient demographics, level of calcification, as well as the description of the lesions 
and PTA-balloons in the PTA group. 
Patient 
no. 
Age Gender 
Calcification 
level 
Lesion 
PTA-Balloon 
Location 
Length 
(mm) 
19 91 F Moderate Distal SFA 50 ∅4 x 40 mm 
20 74 M Moderate Popliteal 80 ∅3.5 x 150 mm 
21 75 M Severe 
Mid SFA / 
Distal SFA 
180 ∅5 x 100 mm 
22 66 F Moderate Distal SFA 40 ∅4 x 40 mm 
23 70 M Moderate Mid SFA 40 
∅6 x 60 mm 
(Drug)  
24 57 F Moderate Distal SFA 10 ∅4 x 20 mm 
25 49 M Severe Mid SFA 100 ∅6 x 100 mm 
26 71 M Moderate 
Mid SFA / 
Distal SFA 
10 ∅6 x 40 mm 
27 80 F Moderate Popliteal 40 ∅5 x 40 mm 
28 58 M Moderate 
Mid SFA / 
Distal SFA 
50 ∅5 x 40 mm 
29 70 F Moderate 
Mid SFA / 
Distal SFA 
40 ∅4 x 60 mm 
30 70 F Moderate Popliteal 100 ∅4 x 40 mm 
31 71 F Moderate Popliteal 30 
∅6 x 40 mm 
(Drug)  
32 83 M Severe Popliteal 60 ∅3.5 x 40 mm 
33 65 F Severe 
Mid SFA / 
Distal SFA 
120 ∅6 x 40 mm 
34 75 M Severe 
Mid SFA / 
Distal SFA 
180 ∅5 x 100 mm 
35 59 F Moderate Distal SFA 10 ∅4 x 20 mm 
Avg ± SD     71 ± 53  
 
3.2.2. 3D Reconstruction of the Arterial Centerline 
The 3D reconstruction of the arterial centerlines relies on a pair of angiographic images, which 
were interactively selected out of the series of images, having a view angle larger than 25°. 
The initial step is to calibrate the 2D images via the calibration phantom. The phantom consists 
of 16 radiopaque spherical fiducials which are projected onto the angiographic images as black 
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circular spots (Fig. 3.1). The particular 2D fiducial positions, together with a priori 3D 
information on the fiducial locations, were used to calibrate each angiographic image111. The 
resulting calibration parameters provide accurate information on the spatial relationship of 
the acquired images. Based on this spatial relationship, corresponding 2D image locations can 
be triangulated to a unique 3D position. This triangulation concept was used to retrieve the 
3D information of the arterial centerline112.  
 
Figure 3.1. The phantom that is attached to the patients’ legs during image acquisition is used 
to calibrate the 2D angiographic images using the fiducials embedded into its surface. 
The arterial boundary was defined by picking 2D image points along its projected outline (Fig. 
3.2a & 3.2b). After defining the arterial boundary in one image, the beginning and the end of 
the artery are represented on the second view in terms of two epipolar lines. These lines are 
used as a guidance to outline the boundary of the artery in the respective other view. The 
defined boundary points were further interpolated and pairs of opposing boundary points 
were used to compute respective center points. The set of 2D center points from both views 
were then triangulated to retrieve the arterial centerline in 3D. A surface model of a 
reconstructed arterial tree is shown in Fig. 3.2c & 3.2d. 
In order to identify the correspondences between straight and flexed positions, certain 
landmarks have been placed at the stent/balloon ends and to corresponding side-branches 
between each image using the epipolar constraint. Furthermore, to make sure that the same 
arterial regions were being considered between pre- and post-treatment images, the 
landmarks at the stent/balloon ends were projected onto the pre-angioplasty images to 
accurately identify the lesion ends. All the landmarks were extracted as 3D points. 
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Figure 3.2. Pair of angiographic images with the semi-automatically extracted arterial tree (a) 
(b); reconstructed 3D arterial tree on top of a radiograph (c); the reconstructed 3D arterial 
tree (d). 
Reconstruction Analysis 
To analyze the multi-view reconstruction capability, the forward- and backward projection 
accuracy of the arterial tree was assessed with respect to an additional validation view. This 
validation view was also interactively selected, whereas the view direction had to be different 
(at least 20° apart) than the two views used for 3D reconstruction. The forward projection 
error results out of the average error distance between the projected points (from the 
reconstructed model) and the extracted boundary information (defined in the validation 
view). The backward-projection error is determined by computing epipolar lines for each 2D 
centerline point (of main branch and side-branches) of the validation view and computing the 
distance to the closest vertex of the reconstructed model. 
3.2.3 Arterial Deformations 
A previously established methodology has been adopted to estimate the arterial 
deformations.21 The calculations were directly performed on the reconstructed arterial 
centerlines. The centerline was divided into 3 segments defined by the landmarks that were 
used to identify the correspondences between straight and flexed positions (i.e. proximal to 
lesion, lesion center and distal to lesion for the pre-treatment measurements; and proximal 
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to treated region, stented/ballooned region and distal to treated region for post-treatment 
measurements). The sample sizes for each segment is reported in Table 3.2. 
The arterial deformations that were investigated in this study were the changes in length and 
curvature due to flexion of the leg. The lengths of the individual arterial segments were 
estimated by calculating the total linear distance between the landmarks defining the 
boundaries of each segment. As such, the axial deformation was defined as the change in 
length between flexed and straight positions, divided by the undeformed length in the straight 
position. 
The curvature at a single location was measured by fitting a circle to 3 consecutive points on 
the centerline21. The distance between each consecutive point corresponded to the average 
arterial diameter and was updated with respect to the investigated FP region. The curvature 
was defined as the inverse of the radius of the circle. By moving this circle along the entire 
centerline, the complete curvature profile of an arterial segment was obtained. Both the mean 
and maximal curvature changes were then calculated as the difference between the curvature 
profiles in the straight and flexed positions.  
Statistical significance regarding the effects of leg flexion, as well as the influences of stent 
implantation and balloon angioplasty, on arterial deformations were assessed using paired t-
tests with a level of 5%. 
3.3. Results 
For each of the 18 patients, four angiographic datasets (pre- and post-angioplasty in straight 
and flexed position) were analyzed. For one patient (patient 2), the artery reconstruction was 
not possible in the pre-angioplasty stage as the main branch was only partially visible due to 
severe arterial calcification. 19 datasets were available for assessing the reconstruction 
accuracy. The average angle between a pair of views used for 3D reconstruction was 37.9 ± 
8.0° and between the validation view and its closest view used for reconstruction was 28.5 ± 
9.1°. The forward projection error was 1.18 ± 0.28 mm on average (max. error: 1.44 mm) and 
the average backward reconstruction error was 1.03 ± 0.15 mm (max. error: 1.24 mm).  
Prior to endovascular treatment, the arterial segments of all samples shortened with leg 
flexion (Table 3.3). Within the lesion, the average shortening was higher for the stent group (-
6.4% ± 3.4%) than the PTA group (-4.6% ± 3.0%). However, this difference was not statistically 
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significant (P: 0.11). Furthermore, it was not possible to make a relevant comparison in the 
proximal regions as there was only one patient data for the pre-stent proximal group. 
Regardless of the treatment method, the shortening behavior was preserved for all segments 
after the operation. For the patients treated only with PTA, the average shortening within the 
ballooned regions (-7.6% ± 4.9%) increased compared to the diseased regions (5.0% ± 2.3). On 
the other hand, patients that have received stents showed a statistically significant decrease 
in the average shortening within the stented regions as opposed to their pre-treatment 
counterparts (post-stent: -3.2% ± 2.9% vs. pre-stent: -6.4% ± 3.4%, P: 0.005). Consequently, a 
statistically significant increase in the axial flexibility of the treated arterial segment was 
observed when the treatment did not involve primary stent implantation (post-balloon vs. 
post-stent P: 0.004).  
The mean and maximal curvatures of all the arterial segments increased with leg flexion. For 
both the diseased and treated regions, the average curvature values nearly doubled with the 
flexion (Table 3.3). Prior to the treatment, there were no statistically significant differences 
between the curvature behaviors of the stent and PTA groups either within the lesion or distal 
to the lesion. Likewise, the average curvature values in these regions were similar before and 
after treatment (Table 3.3). However, similar statements for the proximal regions could not 
be made due to limited data in the pre-stent proximal group. 
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Table 3.3. The axial deformation and the mean and maximal curvatures of the FP arteries due to a hip/knee flexion of 20°/70° within the lesions and 
regions that are proximal or distal to the lesions. The measurements correspond to the average deformations performed prior to PTA, divided into 
their respective groups of only ballooned (Pre-PTA) and stented (Pre-Stent) after PTA only (post-PTA); and following primary stent implantation 
(post-stent). The P values show the effect of leg flexion on the mean and maximal curvatures of the arteries obtained from paired t-tests.  
 
Sample 
Size 
Axial 
Deformation 
(%) 
Curvature (cm-1) 
Mean Maximal 
Straight Flexed ∆ P Straight Flexed ∆ P 
  Pre-PTA 17          
Proximal to lesion 14 -5.0 ± 2.3 0.05 ± 0.02 0.07 ± 0.02 0.02 ± 0.01 0.031 0.10 ± 0.03 0.14 ± 0.05 0.08 ± 0.05 0.041 
Lesion 17 -4.6 ± 3.0 0.07 ± 0.02 0.12 ± 0.08 0.05 ± 0.07 0.028 0.13 ± 0.05 0.26 ± 0.17 0.18 ± 0.16 0.025 
Distal to lesion 14 -11.5 ± 4.0 0.06 ± 0.02 0.17 ± 0.16 0.11 ± 0.15 0.060 0.11 ± 0.04 0.30 ± 0.25 0.24 ± 0.25 0.038 
Pre-Stent 18          
Proximal to lesion 1 -8.0 0.06 0.17 0.11 - 0.11 0.34 0.28 - 
Lesion 18 -6.4 ± 3.4 0.05 ± 0.02 0.09 ± 0.04 0.04 ± 0.03 0.004 0.12 ± 0.04 0.19 ± 0.08 0.12 ± 0.04 0.008 
Distal to lesion 15 -12.9 ± 3.6 0.06 ± 0.02 0.16 ± 0.05 0.10 ± 0.06 0.005 0.13 ± 0.05 0.33 ± 0.12 0.28 ± 0.14 0.004 
Post-PTA 17          
Proximal to lesion 14 -4.4 ± 3.6 0.04 ± 0.02 0.06 ± 0.01 0.01 ± 0.02 0.097 0.08 ± 0.02 0.11 ± 0.03 0.05 ± 0.05 0.036 
Lesion 17 -7.4 ± 5.3 0.07 ± 0.02 0.13 ± 0.07 0.06 ± 0.06 0.003 0.13 ± 0.03 0.25 ± 0.15 0.19 ± 0.12 0.005 
Distal to lesion 15 -11.6 ± 4.3 0.06 ± 0.02 0.20 ± 0.18 0.15 ± 0.17 0.120 0.11 ± 0.04 0.29 ± 0.23 0.25 ± 0.21 0.130 
Post-Stent 18          
Proximal to lesion 14 -8.7 ± 8.7 0.05 ± 0.02 0.13 ± 0.09 0.08 ± 0.10 0.094 0.10 ± 0.04 0.24 ± 0.19 0.18 ± 0.19 0.082 
Lesion 18 -3.2 ± 2.9 0.06 ± 0.02 0.09 ± 0.05 0.03 ± 0.04 0.003 0.11 ± 0.05 0.21 ± 0.16 0.16 ± 0.14 0.004 
Distal to lesion 15 -9.3 ± 6.7 0.07 ± 0.02 0.16 ± 0.08 0.09 ± 0.07 < 0.001 0.13 ± 0.04 0.30 ± 0.16 0.24 ± 0.18 < 0.001 
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Within the regions proximal to the treated segments, the mean and maximum curvature 
values in the flexed positions were significantly higher with stented arteries than when only 
PTA was performed (mean curvature: P: 0.008; max curvature: P: 0.02). For the remaining 
arterial segments, the average curvature values did not show any significant differences 
between different treatment methods. Despite this, stent implantation resulted in notable 
arterial kinking in seven patients (Fig. 3.3). The kinking almost always occurred when the 
stents were implanted towards the popliteal artery and within 1 cm of the distal stent end. 
The only exception was that of one patient who had the stent implanted along the full length 
of the popliteal artery, which resulted in the kinking to occur in the distal SFA, 1 cm to the 
proximal end of the stent. There was no visible evidence of arterial kinking in the arteries 
treated with PTA. 
 
Figure 3.3. Angiographic images of the FP arteries of 4 patients acquired prior to PTA (a, c, e) 
and following primary stent implantation (b, d, f) and with a hip/knee flexion of 20°/70°. For 
all cases, the placement of the stents in the higher deformational segments of the FP artery 
increased the arterial curvatures compared to the pre-treatment phase, leading to extreme 
deformations, such as arterial kinking, with leg flexion.  
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With regards to the different anatomical sections along the FP artery, the average maximal 
curvature change in the popliteal artery (pre-angioplasty: 0.32 ± 0.18; post-balloon: 0.29 ± 
0.13; post-stent: 0.34 ± 0.16) was always significantly higher than both the distal-SFA (pre-
angioplasty: 0.11 ± 0.08; post-balloon: 0.07 ± 0.02; post-stent: 0.16 ± 0.16) and mid-SFA (pre-
angioplasty: 0.07 ± 0.05; post-balloon: 0.07 ± 0.07; post-stent: 0.12 ± 0.11). No significant 
differences were found in the bending behaviors between the distal-SFA and mid-SFA. Finally, 
based on unpaired t-tests conducted between the stent groups of Pulsar-18, Everflex and 
Zilver-PTX, the differences between the arterial deformations caused by different stent 
designs were not found to be statistically significant. 
3.4. Discussion 
The main drawback of endovascular therapy in the FP arterial tract is the risk of restenosis.74,89 
Recent clinical trials reported the long-term restenosis rates in that challenging arterial 
segment to be 17% with drug-eluting stents27 and 20% with drug-coated balloons.132 While 
these numbers are an improvement over the long-term outcomes obtained with non-coated 
devices,103,115 they also further underline the hypothesis that the persisting restenosis rates 
can be attributed to the mechanical deformations of the FP artery.  
The healthy FP artery deformations have been the subject of numerous studies16,17,31,63,88. 
However, comparisons between these studies (i.e. old vs. young patients; living vs. cadaveric 
subjects) show that the deformations are heavily dependent on the composition of the 
arteries.16,88 As such, these studies can only present limited information to improve current 
treatment methods and devices. To this end, it is crucial to analyze the deformations of 
arteries with PAD prior to and after endovascular treatment. Such studies would not only 
provide information on the arterial deformations of the target population, but also on the 
mechanical state of the artery resulting from different treatment modalities. Therefore, the 
aim of this study was to estimate the in-vivo deformations of 35 FP arteries with PAD prior to 
endovascular treatment and immediately after PTA or primary stent implantation. 
The reported reconstruction errors correspond well with data published in literature. Based 
on 4-5 projections of the coronary artery, Liao et al. reported a mean back-projection error of 
1.18 mm.71 The RMS forward projection error of the FP arterial centerline was reported by 
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Klein et al. to be 2.13 mm for the leg in straight position and 1.61 mm for the leg in flexed 
position.62 
For all FP segments, the lengths of the arteries shortened and their mean and maximum 
curvatures increased as the leg moved to a flexed position (Table 2). This general deformation 
behavior was found to be similar before and after acute stent implantation and balloon 
angioplasty. Furthermore, both the axial deformation and curvature behaviors within the 
lesion showed no significant differences between the pre-stent and pre-PTA groups. This 
suggests that the choice of the treatment method was not influenced by the arterial 
deformations of the diseased arteries. 
The treatment had a statistically significant effect on the axial deformation behaviors of the 
diseased segments due to leg flexion. Performing plain balloon angioplasty resulted in 
increased axial shortening, while primary stent implantation led to decreased axial 
compressibility. On the other hand, both procedures had a limited impact on the axial 
deformations of the regions distal to the diseased segments. Similarly, PTA had no effect on 
the axial behavior of the artery in the proximal regions. 
Stented arteries had a significantly higher mean and maximum curvature values compared to 
the arteries that underwent only PTA in the regions proximal to the treated segments. 
However, there was only one valid patient data corresponding to the segment proximal to the 
lesion in the pre-stent group. As a result, it’s not clear if the statistically significant differences 
observed between the mean and maximum curvatures of stented and ballooned arteries were 
already present prior to the treatments or are caused by the different treatment methods. 
Within the treated and distal-to-the-treated segments, the average bending behavior of the 
FP arteries due to leg flexion was similar between the two treatment methods. However, 40% 
of the patients that received stents exhibited arterial kinking either distal or proximal to the 
stent ends immediately after the procedure (Fig. 3.3). In contrast, arteries that were only 
treated with PTA were not associated with kinking and, in one patient, the procedure was 
even found to resolve an identified case of kinking observed before treatment, resulting in a 
smoother bending behavior (Fig. 3.4). 
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Figure 3.4. Angiographic images of the FP artery of one patient acquired prior to (a) and 
following (b) PTA and with a hip/knee flexion of 20°/70°. Performing PTA resolved the arterial 
kinking observed in the pre-treatment phase and returned the artery to a more natural 
deformation behavior. 
Our results suggest that the restrictions imposed by the stents on the axial shortening 
capabilities of the arteries are liable to produce extreme arterial deformations. Due to the FP 
artery’s posterior location to the knee joint, the overall arterial length is expected to decrease 
during flexion. If the artery is not able to compress axially, the additional tissue would either 
form a curve of its own or join a pre-existing curve, resulting in an increased curvature profile 
and, possibly, arterial kinking. This is especially true for the cases, in which stent implantation 
occurs in the segments of the FP artery that undergoes greater deformation with leg flexion, 
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such as the distal-SFA and the popliteal artery40,63,87,112. The comparisons between the two 
treatment methods further support the relation between arterial kinking and increased axial 
stiffness of the artery due to stent placement. 
Previous clinical studies have suggested that chronic arterial kinking may disrupt the natural 
blood flow, leading to restenosis or reocclusions.4 In our case, 20% of the patients showed 
symptoms of restenosis within six months following the operation. Among them, four patients 
exhibited arterial kinking following treatment. This distribution of the data results in an odds 
ratio of 5.0, suggesting that the possibility of restenosis increases with the presence of arterial 
kinking. Based on this observation, the “leave-nothing-behind” strategy could be considered 
as the optimum treatment approach, as performing only balloon angioplasty helped restore 
the natural deformation behavior of the FP arteries. However, bail-out stenting will continue 
to be utilized for arteries that are suspected to collapse without the presence of a stent. 
Therefore, to decrease the possible restenosis rates caused by stent implantation, future 
stents would benefit from designs that enable axial shortening during leg flexion. Another, 
albeit a more controversial, solution, would be to place an additional stent into the arteries 
that experience kinking. This would help smoothen the transition of the mechanical stiffness 
between the stented segment and the adjacent bare artery. The major risk with this approach 
concerns the formation of stenosis due to stenting a healthy artery, which may be prevented 
to a certain extent by using drug-eluting stents. 
Due to the limited number of studies and the differences between their methods, a direct 
comparison of our results with previous publications is difficult. The average axial shortening 
and mean and maximum curvatures from the pilot study presented in Chapter 2 compare 
favorably with our current pre-angioplasty measurements within the lesion.44 However, 
contrary to the outcomes observed from that pilot study, no correlation between the 
curvature behavior and level of calcification was observed. Nikanorov et al. measured the axial 
elongation, bend radius and deflection angle on 17 patients that were only implanted with the 
Absolute (Abbott Vascular, Santa Clara, CA, USA) self-expanding stent.87 With a 70°/20° 
knee/hip flexion, they reported a mean axial compression of 2.4% ± 0.4% in a combined 
segment of the SFA/proximal popliteal (2 patients) and a mean curvature of 0.1 cm-1 in the 
popliteal artery (6 patients). Finally, Ganguly et al. reported a mean axial shortening of 4% ± 
3% and a mean curvature change of 0.05 cm-1 in the stented femoral arteries (unknown stent 
types) of 13 patients with an unknown degree of leg flexion.40 The results from both studies 
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compare favorably with our observations. The differences can be attributed to the number of 
patients included in the study, to the different stent designs implanted in the patients and to 
the different methods used to perform the measurements. 
The main limitation of the present study concerns the reconstruction of the 3D models from 
only two 2D radiographic images. Due to the sparse number of views the identification of 
corresponding side-branches was not possible in most cases. Besides changes to the artery’s 
length and curvature, leg flexion also causes twisting of the FP artery. However, the twist angle 
could not be measured as it requires the accurate position of the side branches and their 
deviation from the main branch. Due to mismatched field of views between the angiographic 
images, the severity of the calcifications and, in some instances, the lengths of the lesions, it 
was not always possible to identify the proximal and distal regions, leading to varying 
reductions in the sample sizes of these sub-groups. However, with the exception of one sub-
group, the inclusion was above 80%, thereby providing a sufficient number of datasets to 
allow for relevant statistical evaluations. All the calculations were performed on two static 
positions, so the measurements actually represent the arterial deformations at a single point 
that is found during the walking cycle rather than considering a dynamic walking situation, 
which includes the effect of muscle contraction on the arterial shape. Finally, a follow-up study 
is needed to further support the hypothesis that arterial kinking significantly increases the risk 
of restenosis.
3.5. Conclusion 
The current study showed the different effects of the available endovascular treatment 
methods on the FP artery deformations. In this context, PTA was observed to help in 
recovering the natural deformation behavior of the artery. On the other hand, stent 
implantation limited the artery’s axial compressibility during leg flexion, which led to arterial 
kinks when the stents were implanted in the segments of the FP artery that are normally 
subject to large deformations. As arterial kinking is associated with restenosis and 
reocclusions, our results would favor the leave-nothing-behind approach for the FP artery 
revascularizations. However, for arteries that require stent implantation, the current stent 
designs should be improved to allow for greater shortening with leg flexion.
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Chapter 4 
Nitinol Stent Oversizing in Patients 
Undergoing Popliteal Artery 
Revascularization: A Finite Element 
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4.1. Introduction 
Peripheral arterial disease (PAD) is commonly treated by endovascular means.47 Restenosis 
remains the major drawback of endovascular revascularization and may affect up to 70% of 
patients undergoing plain balloon angioplasty of the femoro-popliteal (FP) arteries.107 The 
introduction of self-expanding Nitinol stents has reduced restenosis rates within these arterial 
segments to about 40% depending on arterial lesion morphology.108 Two main explanations 
have been proposed to explain the restenosis subsequent to Nitinol stent placement; stent 
fractures105 and chronic irritation of arterial walls during or following stent deployment.51 
While stent fractures may be explained by the high mechanical loads acting upon the stent 
during flexion of the leg44, arterial wall damage may result from oversizing of Nitinol stents, 
which is frequently performed to achieve large luminal gain and to prevent stent 
migration.101,137 
Several investigations have been performed to evaluate the effect of stent diameter on the 
risk of restenosis.11,61,93,101,137 A correlation between Nitinol stent oversizing and restenosis 
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has been evaluated using animal models, for which oversized stents have been implanted in 
healthy arteries of Yucatan swine137, mini-pigs101, canines11,61 and humans.93 Based on these 
studies, it is difficult to assess the clinical effect of Nitinol stent oversizing a few months 
following endovascular intervention. In some studies, stent oversizing was associated with 
adequate luminal gain immediately during the implantation, but ultimately led to excess 
neointimal hyperplasia and restenosis.11,101,137 Other authors reported limited restenosis 
months after implantation of oversized stents.61,93  
A better description of the biomechanical implications of oversizing on arterial tissues may 
help to understand the mechanisms responsible for restenosis and therefore help the 
clinicians to select the appropriate stent size during intervention. There are various structural 
finite element (FE) analyses on stent deployment.22,37,81,96,135,138 Similarly, computational fluid 
dynamics (CFD) simulations have been widely used to investigate the hemodynamic 
properties of stented arteries and their implications for neointimal hyperplasia.15,18,60,66,94,114 
However,  the only numerical studies conducted on stent missizing were found to be on 
balloon-expandable stents deployed in straight cylindrical models of healthy15,66 or calcified 
coronary arteries.128 Due to the significant differences in their deployment procedures, the 
results from these studies could not be adopted for self-expandable Nitinol stents. Thus, the 
aim of the present study was to quantify the biomechanical effects of Nitinol stent oversizing 
using numerical models of non-calcified popliteal arteries obtained from patients undergoing 
endovascular revascularization. Two main aspects were considered; the mechanical effect of 
the stent on arterial walls and hemodynamic alterations induced by stents of varying size. We 
hypothesized that wall stresses increase with increasing stent size, which may lead to chronic 
arterial wall damage. Moreover, we suggested that the presence of an arterial curvature 
would aggravate the effects of oversizing by further increasing arterial stress levels. Finally, 
we hypothesized that oversizing could trigger neointimal hyperplasia in the arterial walls by 
reducing wall shear stress (WSS) and by increasing oscillatory shear index (OSI). 
4.2. Materials and Methods 
Reconstruction of the Patient-Specific Arterial Geometries 
The anatomies of the arterial models were obtained from five patients (4 men and 1 woman; 
age, 56-79 years; mean age 69 ± 9.1 years) undergoing intra-arterial 3D rotational digital 
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subtraction angiography (AXIOM-Artis, Siemens, Germany) prior to endovascular 
revascularization of FP  arteries.44 For 4 patients, the investigated segment of the arterial tract 
started from the descending genicular artery and ended at the superior genicular artery. For 
the remaining patient, the segment ended at the inferior genicular artery. Ethics committee 
approval had been obtained prior to the start of this investigation. Further information about 
the patients and the acquisition process could be found in a previous study.44   
All 3D angiographic examinations were saved digitally and transferred to a workstation 
capable of 3D post-processing. Following the segmentation of the vasculatures on the 3D 
image datasets with an image analysis software (Amira 5.2; FEI Visualization Sciences Group, 
Burlington, MA, USA), arterial centerlines were extracted and shortened to only have the 
section with the maximal curvatures (mean length of 53 mm, with a range of 47-59.5 mm). 
Each centerline was described by 108 points. For each patient, the FE mesh of the artery was 
reconstructed around these centerlines using a script in Matlab (The Mathworks Inc., Natick, 
MA, USA). For each node on the centerline, the script generated 5 rings, each with 128 nodes. 
This meshing approach resulted in the same number of nodes and elements for all the arterial 
models. Furthermore, for longer centerlines, the distance between the rings were adjusted so 
that the element size around the region of stent implantation would be the same as the 
shorter centerlines. Apart from the patient-specific arteries, a sixth arterial model was created 
from a straight centerline to represent a generic, straight artery. The arteries were assumed 
to have a circular cross section of constant diameter. Three concentric arterial layers were 
reconstructed; the intima (5mm – 5.3mm), the media (5.3mm – 5.9mm) and the adventitia 
(5.9mm – 6mm). All of the arterial models had 54,874 linear hexahedral reduced integration 
(C3D8R) elements; 13,696 elements in both intima and adventitia and 27,392 elements in the 
medial arterial layer. The validity of the mesh was confirmed through a mesh sensitivity 
analysis, in which the maximum circumferential stresses in each layer of the artery changed 
by 3% at the diastolic and systolic points of a cardiac cycle.  
Material Model of the Arteries 
The material model adopted for the artery was an anisotropic, hyper-elastic model that 
represented two families of collagen fibers.42,52 The strain energy density function was based 
on the constitutive laws proposed by Gasser et al., which allows not only the specification of 
fiber orientations, but also the inclusion of fiber dispersions within each layer.42 The material 
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parameters for the model were taken from experiments performed on non-calcified iliac 
arteries  (Table 4.1).42,52 The two families of fibers were symmetrically arranged with respect 
to the arteries’ circumferential directions. In accordance with previous findings42, the fibers 
within media were perfectly aligned in circumferential direction (κ = 0); whereas the fibers 
within intima and adventitia were modeled as slightly (κ = 0.02) and highly dispersed (κ = 
0.226), respectively.  
Table 4.1. Material parameters for the individual layers of the artery; intima, media and 
adventitia. 
 Adventitia Media Intima 
C10 (kPa) 7.64 15 31 
k1 (kPa) 996.6 4 51 
k2 524.6 2.3 1.1 
δ1 = δ2 (°) 50 7 5 
κ 0.226 0 0.02 
 
Numerical Models of the Nitinol Stents 
The arterial models were implanted with two commercially available, self-expanding stents: 
Astron-Pulsar and Astron (Biotronik AG, Bülach, Switzerland) (Fig. 4.1). Both stents were made 
of the same shape memory Nitinol, whose material coefficients were provided by the 
manufacturer (Table 4.2). Nevertheless, the stents exhibited different mechanical behaviors 
due to their different designs, with the Astron having larger strut width, thickness and outer 
diameter (119µm, 245µm and 5 mm, respectively) than the Astron-Pulsar stent (80µm, 155µm 
and 3.5 mm, respectively). FE meshes of both stents were produced with 173,160 and 91,248 
C3D8R elements for Astron-Pulsar and Astron, respectively. The number of elements used to 
mesh the stents were determined by sensitivity analyses, in which the maximum principal 
strain values changed less than 2.5% in the stents’ crimped configurations. 
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Figure 4.1. The production geometries of the Astron-Pulsar and the Astron stents showed that 
the Astron had a larger strut width, thickness and outer diameter than the Astron stent. 
Despite the geometrical differences, both stents had the same patterns. 
Table 4.2. Material parameters for the Nitinol model obtained from the laser-cut stent. 
Austenite elasticity EA (MPa) 65,000 
Austenite Poisson’s ratio νA 0.33 
Martensite elasticity EM (MPa) 23,500 
Martensite Poisson’s ratio νM 0.33 
Transformation strain εL 0.046 
Loading LT )( 
       [MPa T-1] 0 
Start of transformation loading 
S
L  (MPa) 
465 
End of transformation loading 
E
L  (MPa) 
535 
Reference temperature T0( C ) 37 
unloading UT)( 
  0 
Start of transformation unloading 
S
U  (MPa) 
227 
End of transformation unloading 
E
U  (MPa) 
187 
Start of transformation stress in compression 
S
CL  (MPa) 582 
Volumetric transformation strain
L
V  
0.046 
 
Structural Simulation Parameters 
Due to the discontinuities induced by the large number of complex contact interactions 
between several components of the model, the structural analyses were conducted with 
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Abaqus/Explicit (Dassault Systemes, Simulia Corp., RI, USA). A semi-automatic stable time 
increment of 4x10-6 was defined to control mass scaling. This increment ensured that the ratio 
of kinetic to internal energy in the system remained below 5% to avoid dynamic effects, which 
guaranteed that the analysis remained quasi-static. To leave the stents constraint free and let 
them find their own mechanical equilibriums, all displacement boundary conditions were 
applied onto the nodes of two rigid cylinders that were meshed with 4 node quadrilateral shell 
elements, with reduced integration (S4R). They surrounded the inner and outer surfaces of 
the stents and acted as expansion and crimp tools (Fig. 4.2). While the undeformed diameter 
of the expansion tool corresponded to the inner diameter of the Astron-Pulsar stent; the initial 
size of the crimp tool was sufficiently large to only contact with the stents when this one 
reaches its unconstrained diameter. The contact between the surfaces was defined as a 
frictionless, hard contact. Additionally, arteries were fixed at both ends with the exception of 
the local radial directions. A total of four cases were considered for each artery, where stents 
with unconstrained diameters of 5.5, 6, 7 and 9 mm were used. 
Preliminary FE Analyses 
Prior to the oversizing analyses, the validity of the arterial model had been evaluated. 
Rectangular strips of each individual arterial layer were subjected to uniaxial extension and 
their mechanical behaviors in axial and circumferential directions had been compared with 
published experimental data.53 Another evaluation of the proposed arterial model was 
performed by calculating the compliance of the artery. The compliance was calculated as the 
ratio of the maximum nominal strain to the maximum pressure change during a cardiac cycle 
and the numerically obtained value was compared with in vivo measurements.122 The 
precision of the models used to simulate the stents was also evaluated. The radial force 
generated by the stents was calculated while crimping the stents to a 1.8 mm diameter 
followed by an expansion to their unconstrained diameters of 9 mm. The radial force was 
compared with experimental measurements provided by the stent manufacturer. Finally, in 
order to ensure a 5 mm lumen at a mean blood pressure of 120 mmHg, the arterial models 
were run through an iterative process38, in which the arterial expansion was estimated under 
the target pressure. The unloaded arterial geometry obtained following the last iteration was 
considered as the stress-free configuration. 
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FE simulations of Stent Deployment 
Accurate calculation of the deployment requires considering the complete stress-strain 
history of the Nitinol stents. Therefore, full stent deployment, involving the preconditioning 
of the stents, was performed for all cases (Fig. 4.2). In the first step, the only active contact in 
the model was between the inner surface of the stent and the outer surface of the expansion 
tool. By radially displacing each node of the rigid tool, the stent was expanded to its desired 
unconstrained diameter. At this stage, the stent was subjected to annealing; a procedure used 
to remove the existing stresses, while preserving the deformed shape. Subsequently, the 
previous contact pair of stent-expansion tool was replaced with a contact interaction between 
the outer-surface of the stent and the inner-surface of the crimp tool. In the next step, the 
stent was crimped to its deployment diameter (1.25 mm for Astron-Pulsar and 1.88 mm for 
the Astron stent) by applying displacements to the nodes of the crimp-tool. During this step, 
a uniform pressure load of 120 mmHg was applied to the inner surface of the arteries to 
expand the lumen diameters to exactly 5 mm, which corresponded to the average lumen 
diameter of healthy arteries in physiological blood pressures.120 Following crimping, the crimp 
tool was deformed into the shape of the arterial centerline to simulate stent insertion. The 
contact pair was modified to include an interaction between the outer-surface of the stent 
with the inner-surface of the artery in addition to the existing stent-crimp tool pair. 
Consequently, during the tool’s radial expansion to its final configuration (which depends on 
the unconstrained stent diameter for each oversizing case), the stent smoothly detached from 
the tool when it came into contact with the inner wall of the artery. After deployment, a cyclic 
blood pressure of ±40 mmHg (i.e. pressure between 80mmHg and 160mmHg) was applied to 
the inner surface of the artery for a total of 3 cycles to simulate a case of isolated systolic 
hypertension, which has been reported to be the most frequent form of hypertension in 
patients suffering from PAD.100 
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Figure 4.2. The preconditioning and deployment of a Nitinol stent into a patient-specific 
popliteal artery. By radially displacing the nodes of the expansion tool (not shown), the Astron-
Pulsar stent is expanded to its unconstrained diameter of 7mm (left). After annealing, the 
stent is crimped to its deployment diameter of 1.2 mm by radial displacement of the nodes of 
the crimp tool (middle-left). The insertion to the patient’s artery is achieved by a 
displacement-controlled deformation of the crimp tool into the shape of the arterial midline 
(middle-right). The crimp-tool is then expanded to its initial diameter, which corresponds to 
the deployment of the stent as it is detached from the tool to contact the arterial walls (right). 
CFD Simulations 
Blood flow computations investigated the effects of different oversizing ratios and the 
performances of both stents in a patient-specific artery. Following stent deployment, the 
deformed meshes of the artery and the stents were exported from Abaqus as open file 
formats (.obj) and converted to surface .stl models using Solidworks 2013 (Dassault Systemes, 
Simulia Corp., RI, USA). These geometries were used for the generation of the computational 
volumetric grids, consisting of approximately 4.5 million tetrahedral elements, in ANSYS ICEM 
CFD (ANSYS Inc., Pittsburg, PA). The computational domain is adequately refined near the 
stent struts and different sizes of the computational grid are tested in a steady-state solution 
to ensure that the results are independent of the applied spatial discretization scheme. The 
analyses were performed with the finite volume code CFX 14.0 (ANSYS Inc., Pittsburg, PA), 
where the following continuity and Navier-Stokes equations are discretized with second order 
accuracy in space and time: 
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where u is velocity (m/s), t is time (s), ρ is density (kg/m3) and p and µ are pressure (Pa) and 
dynamic viscosity (Pa.s), respectively. 
Physiological blood flow was simulated as a transient flow condition by applying the MRI-
measured volumetric flow rate at the inlet of the artery.126 The artery outlet was set to have 
zero pressure and a no-slip boundary condition was prescribed at the arterial wall and stent 
struts. Consequently, the outlet was extended enough to minimize the effects of boundary 
conditions on the accuracy of the simulations. As the plug-flow profile is applied at the inlet, 
it was also extended to reach a realistic blood flow profile. This way, a fully developed 
parabolic flow profile was guaranteed. Blood was modeled as an incompressible Newtonian 
fluid with a density of 1050 kg/m3 and a viscosity of 3.5x10-3 Pa.s.78 Three cardiac cycles were 
calculated using a time step size 0.01 s. Each time step was assumed converged, when 
residuals reduced to 10-6 of their initial values. 
Analysis of Results 
A relation between restenosis and arterial stresses has previously been suggested, with high 
arterial stresses acting as a predictor of restenosis.129 On the other hand, the lack of an exact 
stress threshold that marks the beginning of such a process would only lead to indirect 
suggestions for a safe oversizing ratio. A better approach would be to define an oversizing 
limit based on tissue failure, which could be correlated by experimental findings.53 As a result, 
the maximum circumferential stresses in each layer were compared with their respective 
ultimate experimental stresses to specify the most failure-prone layer in the artery. 
Subsequently, the maximum circumferential stresses in this layer were evaluated to establish 
a correspondence between arterial stresses and unconstrained stent diameters.  
The application of cyclic blood pressures following deployment provided the means to 
conduct fatigue analyses on the stents. The main aim was to calculate the factor of safety 
(FOSNitinol) of the Nitinol stents, which represented the structural integrity of the implanted 
device. Since Nitinol is strain driven, mean strains and strain amplitudes were calculated at all 
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integration points. Using the strain amplitude obtained from the 3rd cycle and a Nitinol 
endurance limit of 0.4%90, FOSNitinol was determined as: 
 
ampNi t i nolFOS 
4.01

    (3) 
where εamp represents the maximum strain amplitude and was calculated as the difference of 
the maximum principal strains between the systolic and diastolic blood pressures. A FOS value 
below +1 corresponds to material failure.  
Spatial and temporal variations of arterial endothelial WSS are believed to play a critical role 
in hemodynamics of intact and stented arteries.97 WSS parameters such as Time-Average WSS 
(TAWSS) and Oscillatory Shear Index (OSI) were derived from the numerically-calculated 
transient WSS field using an in-house MATLAB script and visualized by Tecplot (Tecplot Inc., 
Bellevue, WA). To obtain results independent of the temporal cycles and simulation 
initialization, the data of only the last cardiac cycle was evaluated. TAWSS, as a crucial factor 
to evaluate the hemodynamic status of the stented artery, was defined as56: 
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T
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1

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   (4) 
where, 

w  is the CFD-calculated magnitude of the instantaneous WSS vector (Pa) and T is 
the duration of one cardiac cycle (s). To include the effect of transient oscillation of the blood 
flow, OSI was defined as56: 
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To provide a less-sensitive hemodynamic performance indicator, the surface area exposed to 
low TASSW and high OSI was normalized with respect to the luminal surface area.
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4.3. Results 
The preliminary simulations have been performed to validate the numerical models proposed 
for the artery and the Nitinol stents. The compliance of the arterial tract calculated with the 
model was 7.1% mmHg-1 x 10-2, which corresponded to experimental measurements acquired 
on the popliteal artery of subjects without evidence of PAD.122 Simulations of the arterial 
tissues showed a good agreement with uniaxial traction experiments conducted on each 
individual arterial layer (Fig. 4.3).53 In addition, the radial forces of the stents calculated with 
the model corresponded to the forces measured experimentally (Fig. 4.3). Furthermore, 
mechanical comparison of the two stents revealed that the Astron had a higher radial force 
compared to the Astron-Pulsar during its expansion from 1.8 to 7 mm, thereby making it stiffer 
at the point of contact (about 5 mm) with the artery (Fig. 4.3).  
Following stent deployment, results indicated that adventitia was the arterial layer supporting 
most of the mechanical load (Fig. 4.4). Moreover, adventitia was the most failure-prone layer, 
reaching up to 60% of its ultimate stresses53 for a normal-sized stent and up to 100% of the 
ultimate stresses when the oversizing ratio was 1.8. For all cases, the maximum 
circumferential stresses in this layer increased non-linearly with respect to the unconstrained 
diameters of the Astron-Pulsar stent (Fig. 4.5). Furthermore, the relationship between acute 
luminal gain and stent diameters was also observed to be non-linear. Thus, when stents of 
5.5, 6, 7 and 9 mm diameters were implanted, acute luminal gains were reported to be 7%, 
10%, 11% and 11.5%, respectively (Fig. 4.5).  
The non-linear increase in arterial stresses and lumen gains was similar for both stents in all 
arteries (Fig. 4.5). Due to its higher radial force, the Astron stent produced higher stresses in 
the arteries when compared with the Astron-Pulsar stent at each pressure level (Fig. 4.6). In 
the straight arterial model, the maximum difference between the stresses produced by the 
two stents was about 30% for both normal-sized and oversized stents. This difference 
increased to more than 40% in patient-specific arteries (Fig. 4.6). The artery also had a greater 
expansion with the Astron stent, in which the maximum increase of the lumen gain was 1.5% 
and 2.5% for straight and patient-specific arteries, respectively (Fig. 4.6). 
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Figure 4.3. Uniaxial extension tests of the adventitial layer excised in circumferential (top left) 
and axial (top right) directions are numerically modeled and the resultant stress-strain 
relationships (red) are found to be in range of the diverse mechanical behaviors obtained via 
experiments (blue). The numerically obtained radial forces (green) of the Astron-Pulsar stent 
correspond to the experimental measurements (black) (bottom left).  Additionally, the 
comparison of the radial forces of Astron-Pulsar (black) and Astron (green) stents highlights 
the stiffer nature of the Astron stent (bottom right). 
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Figure 4.4. Following deployment, strains are concentrated at the outer sides of the struts 
(left) and stress distribution in different layers of the artery demonstrates the load-carrying 
behavior of the adventitia (bottom-right). 
 
Figure 4.5. The average maximum arterial circumferential stresses of the patient-specific 
arteries (red) exceed the stress levels observed in a straight artery (black) and show a less 
emphasized non-linear behavior for all blood pressure values (range: 80 mmHg – 160 mmHg) 
(left). Regardless of the arterial geometries, a very small lumen gain is achieved by oversizing 
the stents (right). 
Regardless of the arterial geometry, the fatigue behavior of the Astron-Pulsar stent showed 
similar behaviors. Increasing the unconstrained stent diameters led to an increase in the mean 
strains at the integration points; with the average maximum values being reported as 1.70% 
± 0.51%, 3.38% ± 0.89%, 6% ± 0.07% and 7.07% ± 0.11 for 5.5, 6, 7 and 9 mm, respectively (Fig. 
4.7). In contrast, there was a smaller increase in the strain amplitude with increasing oversizing 
ratios. Consequently, the factor of safety of the stent was found as 5.28 ± 0.1, 4.94 ± 0.11, 
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3.64 ± 0.27 and 1.18 ± 0.11 for 5.5, 6, 7 and 9 mm, respectively. A similar gradual decrease in 
the safety factor of the stent was observed for the Astron as well. 
 
Figure 4.6. The stent with a higher radial force, Astron (green), was found to create 
significantly higher stress levels than the Astron-Pulsar stent (red) (left). In comparison, a very 
limited increase in lumen gain is observed to create a mismatch in arterial stress-lumen 
relationship (right). Regardless of the stent designs, a very small lumen gain is achieved by 
oversizing the stents (right). 
For all deployment cases and for both stent models, spatial structure of blood flow and 
instantaneous patterns of WSS were found to be complex and varying during the cardiac cycle 
(Fig. 4.8). Throughout the cardiac cycle and for the time-integrated parameter, localized areas 
of atheroprone low WSS (less than 5% of maximum WSS i.e. < 0.5 Pa) were seen in regions of 
flow separation, e.g. near the stent struts and inner side of curved artery. Regions of high WSS, 
on the other hand, were likely to occur on the outer side of the arterial curvature and on the 
in-lumen-protruded side of the stent struts. Independent of the stent stiffness, length and 
geometry, larger areas were exposed to low WSS at proximal portions of the stented 
segments. Furthermore, the distribution of OSI, as a measure of temporal WSS change, in both 
stents showed similar traits with the TAWSS distribution. High values of OSI (more than 20% 
of maximum OSI i.e. >0.1) were seen in the vicinity of stent struts, inter-strut connectors, 
proximal segment of stented artery and distal inner wall of the curved artery.  
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Figure 4.7. The fatigue behavior of the Pulsar stent when deployed into a geometrically 
accurate artery with unconstrained stent diameters of 5 mm (top left), 6 mm (top right), 7 mm 
(bottom left) and 9 mm (bottom right): As the oversizing ratio is increased, the strain 
amplitude of more points are found to migrate towards the Nitinol safety limit of 0.4; thereby 
decreasing the safety factor of the stent. 
A direct comparison of all cases showed that increasing the stent-induced arterial diameter 
would raise the normalized surface area exposed to low TAWSS (less than 0.5 Pa), which was 
concurrently more pronounced for the cases stented with the Astron (Fig. 4.9). In addition, 
the deployment of Astron definitively assured that the surface area exposed to high 
atheroprone values of OSI would be bigger than with the Astron-Pulsar (Fig. 4.9). No clear 
relation between the oscillatory features of blood flow and different lateral expansion rates 
was observed.  
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Figure 4.8. Instantaneous pattern of WSS distribution on stented popliteal artery at different 
instants of a cardiac cycle marked by solid red line on a flow rate profile inset. WSS is shown 
at: (A) t = 0.13 second (B) t = 0.44 second and (C) t = 0.64 second. Panel (D) shows how the 
symmetric velocity profile is distorted toward the outer wall owing to arterial curvature. This 
affects the WSS distribution considerably.
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Figure 4.9. Normalized surface area exposed to TAWSS of less than 0.5 Pa (left) and OSI of 
more than 0.1 (right). Oversizing leads to larger areas being exposed to low TAWSS and more 
prominent atheroprone conditions at the arterial wall, which is more noticeable for the cases 
with the stiffer Astron stent. On the other hand, while the local mechanical environment 
induced by oscillatory characteristics of blood flow significantly increase with the deployment 
of Astron, they are not directly affected by stent oversizing. 
4.4. Discussion 
Nitinol stent oversizing is commonly performed during endovascular procedures; however, 
currently, stent sizing mostly relies on the expertise of the clinicians and is defined by stent 
manufacturers and not by objective criteria. While oversizing a stent will undoubtedly increase 
acute luminal gain, it can also create a hostile chronic environment for the artery through 
stent-to-arterial wall interactions, which may ultimately lead to arterial damage, 
neointimal/adventitial hyperplasia and restenosis.101,137 With previous clinical studies 
reporting controversial findings on the subject15,61,93,101, the efficacy of oversizing remains an 
issue to be answered. Thus, to improve the understanding of mechanical effects of stent 
oversizing in the popliteal arterial tract, numerical analyses have been performed within the 
present investigation.  
The hypothesis behind stent oversizing is that oversized stents will limit possible arterial 
restenosis due to acute lumen enlargement. However, results of this study showed a non-
linear relationship between the lumen gain and oversizing ratio (Figs. 4.5 & 4.6). Increased 
oversizing led to a small lumen increase, while generating rapidly increasing arterial stresses. 
This mismatch between the limited lumen gain and elevating stresses can be illustrated by a 
3% lumen vs. 30% stress increase for the Astron-Pulsar stent (4% vs. 33% for the Astron) when 
the stent-to-artery ratio is transitioned from 1.1 to 1.2. Therefore, our results suggest that 
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instead of providing an additional lumen gain, stents with higher oversizing ratios inflict 
greater chronic arterial damages through increased chronic arterial stresses.  
A comparison between the numerical and experimental results indicated that increased 
oversizing, the level of arterial stresses came close to the failure limits of the tissues, which 
have been obtained via uniaxial extension tests .53 Independent of the stent design, adventitia 
was found to be the most vulnerable layer due to its highly nonlinear mechanical response at 
pressures above 80 mmHg.110 The high risk of failure in this layer further suggests that normal 
sized stents are more favorable to protect arterial walls from chronic damage and, 
consequent, neoadventitial hyperplasia.110 
Results of the numerical calculations showed that both the maximum arterial circumferential 
stresses and the luminal gains increased non-linearly with respect to the unconstrained stent 
diameters regardless of arterial geometries and stent designs (Fig. 4.5). Comparisons between 
straight and patient-specific geometries showed that the latter exhibited slightly less 
pronounced non-linear increase of the mechanical parameters with increased oversizing. This 
may be explained by distinctive deformations exerted onto different arterial geometries 
during stent deployment. While the straight artery was only displaced radially, the curved 
arteries were subjected to straightening alongside radial expansion. This effect not only 
caused an overall increase of the circumferential stresses for each oversizing ratio, but also 
led to higher stress differences between oversized and normal-sized arteries. 
The successful outcome of an endovascular procedure not only lies in selecting the correct 
stent size, but also in selecting the correct stent design. In the present study, the 
disproportionate increase between lumen gain and arterial stresses for successive oversizing 
ratios was similar for both stents (Fig. 4.6). On the other hand, oversizing the Astron stent to 
the ratio of 1.2 increased the risk of failure considerably when compared with the Astron-
Pulsar stent. Furthermore, a maximum difference of 2.5% was observed between the lumen 
gains achieved at this oversizing ratio (Fig. 4.6). This value remains small when compared with 
their corresponding stress difference of 37% (Fig. 4.6). Therefore, this mismatch between the 
changes in the stresses and lumen diameters suggests that radial force would have an impact 
on the processes observed during clinical follow-up, as stents with higher radial forces would 
likely inflict more chronic irritation to arterial walls when compared with their less stiff 
counterparts. 
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Individual patient anatomies in the present study all showed different curvatures. However, 
no relation between the fatigue behavior of either the Astron-Pulsar or the Astron and arterial 
geometries was observed. Instead, the stents performed similarly for all curved arteries. This 
may be explained by the fact that an identical systolic-diastolic pressure behavior was applied 
to all models.96 The safety factor of the Astron-Pulsar stent was found to decrease with 
increasing oversizing ratio, which can be explained by the higher deformations exhibited by 
oversized stents due their incomplete expansions at deployment. Although the calculated 
fatigue criterion remained below the failure level, stents with 9 mm diameters came close to 
the Nitinol endurance limit of 0.4% (Fig. 4.7)90, without even considering the mechanical 
forces acting on the stent due to the physiological loading present in lower limb arteries44. 
This result suggests that oversizing increases the risks of stent failures, which has been directly 
related with restenosis.65   
Physiological stressors such as near-wall flow, which directly perturb intra- and extracellular 
signaling, proved to be a reliable predictor for local biological responses of stented arteries12. 
Thus, studying the hemodynamic performance of implanted stents and considering 
procedural variabilities, such as oversizing, could be used to provide clinicians with accurate 
observations on the causes of adverse biological effects. Local flow patterns are proved to 
affect the neointimal formation, in-stent restenosis and thrombosis in stented arteries. 
Therefore, computed indices of flow were calculated here to support the hypothesized 
drawback of stent oversizing. The critical values of low WSS and high OSI, which are reported 
to correlate with adverse clinical outcomes97, were found to be similar to already published 
studies.98 Stent oversizing considerably perturbed the local flow patterns, specifically the 
near-wall flow, due to the abrupt change in the proximate bounding geometry. The procedure 
was found to increase the normalized surface area exposed to low TAWSS, leading to a large 
area of the stented artery to be susceptible to unfavorable biological responses. The abrupt 
change of arterial size and the expanded cross-section would decrease the blood flow and the 
WSS in the vicinity of the stented wall (Fig. 4.8). For cases where significant lumen gain is not 
achieved, this would depress the hemodynamic efficiency of the oversized stent and seriously 
question its clinical expediency. In contrast, the larger surface area exposed to high OSI was 
not affected by the stent-to-artery ratio (Fig. 4.9). This may be mainly related to the specific 
shape of the stent and curvature of the artery, wherein the secondary flow generated by the 
arterial curvature and recirculation zones induced by the stent will have a combinatory effect 
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on the oscillatory characteristics of the blood flow. For the cases implanted with the Astron 
stent, larger deformations were induced in the artery walls around the stent struts, which 
resulted in a larger alteration of near-wall flow compared to the more flexible Astron-Pulsar 
stent. Consequently, computed indices of flow such as velocity and WSS are more affected 
when stiffer stents are used. In conclusion, stent-induced oversizing of the arterial wall, 
independent of the stent type, would deteriorate the hemodynamic performance of 
peripheral stents, wherein the arteries fitted with stiffer stents become more vulnerable.  
The validity of the proposed arterial model was verified by comparing the numerical 
simulations with published experimental data. The individual behaviors of each arterial layer 
obtained via traction simulations, as well as the overall compliance of the artery, matched well 
with existing measurements (Fig. 4.3).53,122 Furthermore, the mechanical behavior of the 
adventitia is similar to previous reports110, as it became the mechanically predominant layer 
when the physiological blood pressure of 13.3 kPa is exceeded. These comparisons indicated 
that the present arterial model is appropriate to evaluate arterial stenting. Finally, the 
immediate lumen gain values obtained from the deployment simulations were compared with 
a clinical investigation that performed Nitinol stent oversizing in the femoral arteries of 
Yucatan swines137. These clinical findings compared favorably with the lumen gains obtained 
in our study for high oversizing ratios (>1.4). On the other hand, numerical models with lower 
oversizing ratios (<1.4) predicted a larger lumen gain, which can be attributed to the difference 
between the numerical and clinical arterial diameters prior to stenting. 
Several limitations to the present study need to be discussed. Only healthy arteries were 
modeled and stented, while stents are generally implanted in diseased arteries. The inclusion 
of plaques into the model would not only change the stress/strain values, but would also have 
an impact on the location of maximum stress/strain concentrations in the arterial models. 
However, based on current understanding, deployed stents usually overlap with the non-
obstructed parts of an artery, thereby exerting potential effects caused by stent oversizing on 
both healthy and diseased sections. Moreover, pre-clinical investigations have so far used 
healthy animal arteries to investigate the effects of oversizing. Thus, the results could easily 
be compared to validate the numerical models. Only two stent designs were used in this study. 
Although the effects of oversizing are not expected to change with different stent designs, the 
level of stress and lumen expansion may show differences. Performing similar calculations for 
different designs could work towards achieving an average value for a safe oversizing ratio. 
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Since the present study focused on the parametric evaluation of the stenting procedure, the 
same material model was used for all patient-specific arteries. Due to this parametric 
approach, the conclusion on the effect of oversizing should remain identical for each patient, 
although the exact level of strain may differ. Finally, the residual strains for the arteries were 
not modeled, which may suggest a possible overestimation of the arterial stresses. 
Nonetheless, the nonlinear stress behavior with increasing stent diameters would be the 
same. The accuracy of blood flow simulations depends on the chosen boundary conditions. In 
order to obtain more realistic results, direct experimental measurements should be used to 
define the boundary conditions for blood velocity or pressure at the inlet and outlet. In this 
study, a generic dataset obtained from MRI measurement was applied at the inlet of the 
domain. However, a simplified boundary condition was used at the outlet with a zero 
pressure. To limit the error introduced by this approximation, the outlet was extended to 
maintain realistic flow profiles.  
4.5. Conclusion 
The effects of Nitinol stent oversizing in geometrically patient-specific popliteal arteries were 
evaluated through numerical analyses. A gradual increase of the stent-to-artery ratio from 1.1 
to 1.8 showed the development of both the structural and hemodynamic properties of 
arteries with respect to the normal and oversized stent diameters, while providing the 
framework for fatigue analyses of the stents. The results showed that oversizing had a very 
limited impact on the immediate lumen gains achieved following stenting. At the same time, 
transition to a higher oversizing ratio led to a significant increase in structural and WSS in 
arteries, which can be associated with arterial damage and disruption in the blood flow. Since 
self-expanding stents will continuously apply radial forces to the arterial walls in order to reach 
their nominal diameters, these damages will continue to accumulate, creating a mechanical 
environment prone to induce restenosis. Therefore, to increase the success rate of an 
endovascular procedure in a FP arterial tract that includes healthy popliteal segments, 
clinicians should take care not to oversize Nitinol stents and allow them to contribute to a late 
lumen gain in the arteries.
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Oversizing in Arteries with Peripheral 
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5.1. Introduction 
Endovascular treatment of Peripheral Arterial Disease (PAD) is either performed by 
percutaneous transluminal angioplasty (PTA) or through primary stent implantation following 
revascularization.47,89 In the case of the latter, choosing the correct stent size is crucial to 
simultaneously counteract arterial recoil and prevent extensive damage to the arterial 
tissues.101,137 However, due to a lack of established guidelines, the current clinical practice 
consists of the qualitative selection of the proper stent size based solely on recommendations 
provided by the stent manufacturers. As a result, Nitinol stent oversizing is frequently 
performed to maintain full wall apposition and prevent stent migration.61,93,101,137 Despite 
these perceived advantages, the large stresses inflicted onto the arteries due to oversizing 
might lead to arterial damage and, ultimately, to restenosis.22,51,96,129 
The number of studies on Nitinol stent oversizing in the peripheral vasculatory system are 
scarce. To date, there have only been two animal investigations that have studied the 
implications of coated and non-coated Nitinol stent oversizing in Yucatan swine and mini-
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pigs.101,137 Both studies have defined over-sized arteries  as having a stent-to-artery ratio, i.e. 
the ratio of nominal stent diameter  to lumen diameter of the artery, above 1.4 and suggested 
that while all the arteries have shown neointimal proliferation, only the oversized arteries 
(stent-to-artery ratio > 1.4) were damaged enough to exhibit restenosis. However, these 
studies were performed in healthy arteries and, as such, the results might not be applicable 
to the patient population that undergoes endovascular therapy of the lower limbs. A clinical 
study on stenosed carotid arteries supports this hypothesis, as the results suggest that 
oversized arteries (stent-to-artery ratio between 1.4 and 2.0) yield better outcomes in terms 
of late lumen loss compared to normal-sized arteries (stent-to-artery ratio below 1.4).93 These 
contradictory outcomes can be attributed not only to the differences in the vasculature 
systems, but also to the different morphologies and mechanics between healthy and diseased 
arterial layers. Therefore, to understand the effects of Nitinol stent oversizing on the actual 
clinical practice, the procedure should be evaluated on peripheral arteries with PAD.
Numerical analyses are routinely used to support or replace experiments with the intention 
to analyze the fatigue life of stents.32,75,76,91 They are also frequently used to understand the 
mechanical and hemodynamic behaviors of both healthy and diseased arteries due to stent 
implantation.8,22,45,55 In this instance, the numerical approach is a suitable substitute to 
performing clinical investigations that would be ethically questionable due to a high risk of 
damage to both the plaque and healthy arterial tissues. The majority of the previous numerical 
studies on stent mis-sizing have focused on balloon-expandable stents in coronary 
arteries.14,15,54,66 These studies have shown that stent implantation tends to disrupt the 
natural flow patterns and that oversizing (stent-to-artery ratio > 1.0) negatively impacts the 
Wall Shear Stress (WSS) parameters and, consequently, increases the risk of restenosis. 
However, the results are not directly adaptable either to the endovascular procedures 
performed in lower-limbs or to the common clinical practice due to the differences in stent 
types, their deployment techniques and the use of healthy arterial models. On the other hand, 
the limited number of studies that cover Nitinol stent oversizing in peripheral arteries  
performed the analyses on non-calcified arteries.45 As such, the effects of Nitinol stent 
oversizing on the mechanical behavior of arteries with calcified plaques are currently not 
known. Therefore, the main aim of this study was to investigate the changes in arterial stresses 
and acute lumen gains associated with gradual stent oversizing. The numerical investigation 
was performed using finite element (FE) analyses of endovascular therapy in an artery model 
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that included clinically relevant PAD. A secondary objective was to observe whether the 
effects of oversizing were influenced by the degree of lesion calcification. 
5.2. Materials and Methods 
Components of the FE Simulations 
Five parts were required for the FE modeling of the endovascular therapy; the diseased artery, 
the angioplasty balloon/s, the Nitinol stent, and the expansion and crimp tools. The artery was 
idealized as a straight cylinder with completely healthy sections at both ends and a mix of 
healthy and atherosclerotic tissue at the center for a total length of 35 mm (Fig. 5.1). Each 
healthy section had a length and lumen diameter of 5.0 mm122 and were made of 3 layers55; 
intima, media and adventita with thicknesses of 0.15 mm, 0.25 mm and 0.1 mm, 
respectively.116,119 The diseased section was created by increasing the thickness of the intimal 
layer to reach a luminal diameter that corresponded to 30% of the healthy lumen, which is 
indicative of a clinically relevant PAD. By modifying the mechanical tissue properties of the 
thickened intimal layer to represent an atherosclerotic plaque, the stenosed tissue had been 
directly embedded into the artery. This approach enabled a geometrically smooth transition 
between the healthy and diseased sections and the resultant configuration corresponded to 
a symmetric plaque (Fig. 5.1a). As it was previously shown that femoral plaques are typically 
heavily calcified24,29,50,70, the plaque only included calcification and not any underlying sections 
of lipid pool or fibrotic tissues. Each layer, including the plaque, was discretized with linear 
hexahedral reduced integration elements (C3D8R). In each healthy section, the number of 
elements in intima, media and adventitia were approximately 4,000, 7,000 and 4,000, 
respectively. For the diseased section, the number of elements in the medial and adventitial 
layers were increased by approximately 2 times their healthy counterparts, while the plaque 
was meshed with approximately 50,000 elements. A mesh sensitivity analysis was performed 
to verify that the mesh was sufficiently dense to satisfy the convergence criteria defined in a 
previous study.45 
The initial geometry of the angioplasty balloon corresponded to its fully-expanded 
configuration with a diameter of 5.0 mm and a length of 25 mm (Fig. 5.1b). The balloon had 
4,000 linear quadrilateral membrane elements with reduced integration (M3D4R). A 
commercially available Nitinol stent, Astron-Pulsar (Biotronik AG, Bülach, Switzerland), with 
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production dimensions of 80µm strut width, 155µm strut thickness, 3.5 mm outer diameter 
and 25 mm length was considered for the simulations (Fig. 5.1d). These dimensions 
represented the configuration right after the stent was laser-cut from a Nitinol tube and 
before the in-silico expansion and annealing. The number and type of elements for the stent 
were previously verified and corresponded to 170,000 linear reduced integration elements 
(C3D8R).45 The rigid expansion and crimp tools, which were used for the preconditioning and 
deployment of the stent, were both meshed with linear quadrilateral shell elements with 
reduced integration (S4R). The expansion tool had the same initial diameter as the inner 
diameter of the stent. Conversely, the diameter of the crimp tool corresponded to the 
unconstrained stent diameter achieved at the end of the preconditioning state and, as such, 
varied with each oversizing case (Fig. 5.1d).  
 
Figure 5.1. The complete procedure of an endovascular therapy in an artery with a clinically 
relevant level of PAD (70% stenosis): The pressurization of the artery with the physiological 
blood pressure of 120 mmHg and the positioning of the angioplasty balloon (a), unfolding of 
the angioplasty balloon with a pressure of 7 atm to simulate plaque failure (b), folding of the 
angioplasty balloon and evaluation of the expanded lumen diameter (c), representation of 
the Nitinol stent and the crimp tool in their unconstrained diameters prior to crimping of the 
stent (d), crimping of the Nitinol stent to a crimp diameter of 1.2 mm to simulate insertion 
into the artery (e), and the deployment of the stent into the artery (f). 
71 | Chapter 5. Nitinol Stent Oversizing in Calcified Peripheral Arteries 
 
 
Consitutive Models 
The healthy arterial layers were represented with the Holzapfel-Gasser-Ogden (HGO) model; 
an anisotropic, hyper-elastic material model that includes two collagen fibre families.42,52 The 
material parameters were obtained from uniaxial tensile tests performed on the healthy 
portions of a single diseased external iliac artery acquired from autopsy. The exact values, 
including the fibre orientations and fibre dispersions within each layer, have been reported 
previously.45,52  
The atherosclerotic tissue was modeled as isotropic, hyper-elastic using a 3rd order reduced 
polynomial form (Yeoh) based on the uniaxial experimental data performed on 20 samples of 
human atherosclerotic femoral plaques (Table 5.1).25 The fitting was performed in Abaqus 
v.6.12 (Dassault Systemes, Simulia Corp., RI, USA) by providing the experimental data as the 
input for the material model. Three plaque groups (lightly calcified, moderately calcified and 
heavily calcified) were considered for the analyses. The experimental data showed that the 
lightly calcified plaque underwent high stretch until tissue failure (0.3 MPa at a nominal strain 
of 1.15); while the moderately calcified plaque reached a higher ultimate tensile stress (0.43 
MPa) at a nominal strain of 0.75. This suggests that the moderately calcified plaque was stiffer 
compared to the lightly calcified plaque. On the other hand, both the ultimate tensile stress 
and stretch values for the heavily calcified plaque were lower than the other plaque types 
(0.16 Mpa at a nominal strain of 0.55). This behavior has been associated with the unique 
morphology of the heavily calcified plaque, which differs not only from the other femoral 
plaques, but also from the heavily calcified plaques from other anatomical regions.83 However, 
as a result of its low failure stress and strain, the elastic mechanical response of the heavily 
calcified plaque prior to failure was very similar to the lightly calcified plaque.  
Similar to previous studies that modeled plaque failure during endovascular therapy, a perfect 
plasticity model was adopted to represent tissue damage.19,22,23,32,92 This method allows the 
plaque to undergo plastic deformation, while preventing an increase in its stresses. Once the 
plastic limit is reached, the loads exerted onto the artery are transferred to the healthy layers. 
Upon unloading, the plaque is plastically deformed and the lumen diameter is permanently 
increased. At that point, the stresses in the healthy layers are determined by the extent of 
plastic deformation in the atherosclerotic tissues. The plasticity thresholds in this current 
study corresponded to the failure stress levels of each plaque group (Fig. 5.2).25,26 A 
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justification for using failure stresses as yield stresses in the perfect plasticity model is 
provided in the discussion. 
Table 5.1. Material parameters (C10, C20 and C30) of the Yeoh SEF model for the arteries with 
lightly, moderately and heavily calcified plaques represent the average mechanical behavior 
of the plaque tissue under uniaxial extension tests25,26. The plasticity threshold corresponds 
to the failure stress of the tissues. 
-  C10 (MPa) C20 (MPa) C30 (MPa) Plasticity Threshold 
Calcification    Stress (MPa) Strain 
Light 5.9 10-2 4.4 10-3 -2.7 10-4 3.0 10-1 1.15 
Moderate 1.4 10-1 3.1 10-2 -1.6 10-2 4.3 10-1 0.75 
Heavy 4.7 10-2 1.5 10-2 -1.3 10-2 1.2 10-1 0.55 
 
The angioplasty balloon was modeled with a linear, elastic material model. The material 
parameters, as well as a mass proportional Rayleigh damping coefficient, which was assigned 
to make the folding and inflation of the balloon more stable, were taken from literature.22 The 
material parameters for the super-elastic Nitinol model were provided by the manufacturer.45 
Finally, the rigid crimp and expansion tools were represented with a linear, elastic model 
(Young’s modulus E: 210,000 MPa; Poisson’s ratio ν: 0.3). 
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Figure 5.2. The average stress-strain behaviors of the lightly (n=3), moderately (n=5) and 
heavily (n=12) calcified femoral plaque types under uniaxial tensile tests show that the 
moderately calcified plaque have the highest stiffness; while the lightly and heavily calcified 
plaque types have similar mechanical behaviors prior to tissue failure.25 The tissue damage 
was modeled using perfect plasticity with the heavily calcified plaque reaching its constant 
stress threshold the earliest (160 kPa at a nominal strain of 0.55) and the lightly calcified 
plaque reaching it the latest (300 kPa at a nominal strain of 1.15) (Table 5.1).  
Simulation Parameters 
The simulations were performed using Abaqus/Explicit with a user-defined, semi-automatic 
stable time increment of 4 x 10-6. This value ensured that the kinetic energies of each 
individual part and the whole assembly remained below 5% of their corresponding internal 
energies at any given time during the analyses. As a result, the quasi-static nature of the 
analyses was preserved at all time points of the simulations. A symmetry boundary condition 
was defined at the middle of the angioplasty balloon to prevent it from moving axially during 
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the folding/unfolding steps. Finally, the artery was constrained at both ends to prevent 
movement in the longitudinal axis. A hard, frictionless contact was defined for the interactions 
between the balloon and the artery, as well as between the stent and the artery, using the 
general contact algorithm. On the other hand, the interactions between the tools and the 
stent were established with a surface-to-surface contact methodology, which ensured a 
proper separation of the surfaces. 
Preliminary Analyses 
Prior to the main analysis of endovascular therapy and stent oversizing, the initial 
configurations of the stent, the balloon and the artery were prepared through three 
standalone simulations. The first one was stent preconditioning, which consisted of an initial 
expansion of the stent to its unconstrained diameter, followed by an annealing procedure that 
was performed to remove the stresses and preserve the expanded shape. A total of four 
oversizing ratios, 1.0, 1.2, 1.4, and 1.8, were investigated in this study. The unconstrained stent 
diameter for each case was calculated by multiplying these ratios with the healthy lumen 
diameter (i.e. 5 mm, 6 mm, 7 mm and 9 mm). For this simulation, the contact interaction 
between the outer surface of the expansion tool and the inner surface of the stent was 
activated. Subsequently, the stent was expanded by applying velocity boundary conditions to 
the nodes of the expansion tool. The second simulation was the folding of the angioplasty 
balloon by applying a negative pressure to the balloon’s inner surface. The third and final 
simulation was an iterative process to determine the stress-free diameter of the artery, such 
that the healthy lumen diameter corresponded to the average diameter of the popliteal artery 
(i.e. 5 mm) under the physiological blood pressure of 120 mmHg.120 The deformed, stress-free 
configurations of the stent, the balloon and the artery were, then, brought together in a new 
assembly for the main analysis. In addition to these preparation simulations, the changes in 
the radial force profile of the stent with respect to different oversizing ratios were evaluated 
through further analyses, where the stents were crimped to their insertion diameter of 1.2 
mm and expanded back to their unconstrained diameters. 
Simulation of Endovascular Therapy 
The main analysis included the clinical processes of balloon angioplasty and stent implantation 
(Fig. 5.1). In the first step, the artery was pressurized by applying the physiological blood 
pressure of 120 mmHg on the inner surface of the artery (Fig. 5.1a). Next, the contact pair of 
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balloon-artery was activated, and balloon angioplasty was simulated by applying a positive 
pressure of 7 atm. to the inner surface of the balloon (Fig. 5.1b). Subsequently, the balloon 
was folded and the minimum lumen diameter was checked to evaluate the success of the 
angioplasty (Fig. 5.1c). If the lumen diameter was below 70% of the healthy lumen diameter,32 
then an additional angioplasty was performed using a larger balloon diameter. Following the 
adequate expansion of the lumen, the contact interaction between the inner surface of the 
crimp tool and the outer surface of the stent was activated and the stent was crimped to its 
insertion diameter of 1.2 mm by radially displacing each node of the crimp tool (Fig. 5.1e). 
Finally, the contact pair of stent-artery was activated and the stent was expanded by radially 
expanding the crimp tool to its original position. As the stent came into contact with the artery, 
it detached from the crimp tool and was deployed into the artery (Fig. 5.1f).  
Data Analysis 
The effects of Nitinol stent oversizing were evaluated by analyzing the stress distribution (in 
particular, the 95th percentile) along the circumferential direction in the healthy layers 
surrounding the diseased region and the minimum lumen diameter at the end of 
pressurization, after balloon angioplasty and post stent deployment. 
It is hypothesized that high arterial stresses possibly lead to adverse outcomes in patients.45,129 
Since a stress threshold that puts the artery at risk is unknown, previous studies have 
investigated the effects of stent implantation based on tissue failure22,23, which could be 
corroborated by experimental findings. Similarly, in this study, the 95th percentile stresses 
calculated with the numerical model were compared to the ultimate experimental stresses42 
in the circumferential directions for the healthy layers surrounding the atherosclerotic tissue. 
The arterial layer identified as the most failure-prone was analyzed to establish the effects of 
endovascular therapy and Nitinol stent oversizing.  
For the calculation of the minimum lumen diameter, the position of each node at the arterial 
lumen interface was extracted from Abaqus and exported to Matlab. Along the length of the 
artery, circles were fitted to each of the 108 rings of nodes representing the arterial lumen. 
The diameters of the circles corresponded to the lumen diameters along the length of the 
artery and the smallest one determined the minimum lumen diameter. 
Additionally, the equivalent plastic strain (PEEQ) distributions in the atherosclerotic tissue 
were reported to quantify plaque failure among the 3 different plaque types.
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5.3. Results 
The complete radial force profile of the stent clearly showed the super-elastic behavior of the 
Nitinol material,121 where the stent’s outward force remained near-constant across a wide 
range of diameters during crimping and deployment into the artery (Fig. 5.3). Increasing the 
oversizing ratio resulted in a higher radial force to be applied by the stent onto the artery 
during deployment. This difference was highest between the unconstrained stent diameters 
of 5 and 6 mm, which exhibited a 40% increase in the stent’s radial force. The difference in 
the radial force was smaller – approx. 20% - when the unconstrained stent diameter increased 
from 7 to 9 mm. In contrast, the change in stent’s radial force is nominal (approx. 5%) between 
the unconstrained stent diameters of 6 and 7 mm. 
 
Figure 5.3. The radial force profiles of the Nitinol stent for each of the unconstrained stent 
diameters showed that increasing the oversizing ratio led to an increase in the radial force of 
the stent during crimping and deployment into the artery. As a result, the 9 mm stent exerted 
the highest radial force onto the artery, whereas the 5 mm stent exerted the lowest. On the 
other hand, the difference between the radial forces of the 6 and 7 mm stents during 
deployment was found to be marginal. For visualization purposes, the full radial force profile 
during the crimping and deployment of stent is only shown for the 9 mm stent.  
77 | Chapter 5. Nitinol Stent Oversizing in Calcified Peripheral Arteries 
 
 
Under the physiological blood pressure of 120 mmHg, the circumferential stresses in the 
healthy layers surrounding the diseased region, as well as the minimum lumen diameters, 
were comparable between the different plaque groups (Table 5.2). This suggested that all the 
artery models were in a similar mechanical condition prior to balloon angioplasty. The initial 
PTA with a 5 mm angioplasty balloon yielded different outcomes for the three plaque types. 
The minimum lumen diameters for the vessels with lightly, moderately and heavily calcified 
plaques were 2.5 mm, 3.2 mm and 3.4 mm, respectively (Table 5.3). At this stage, only the 
vessel with heavily calcified plaque satisfied the requirement to continue with stent 
implantation, as it was the only arterial model that reached a diseased lumen diameter 
corresponding to 70% of the healthy lumen diameter.32 This can be explained by the low 
stress-strain threshold (0.16 Mpa at a nominal strain of 0.55) required to start the plastic 
deformation process in the heavily calcified plaque. As a result, the heavily calcified plaque 
underwent greater plastic deformation than both the moderately and lightly calcified plaques, 
which reached their constant stress thresholds at considerably higher strain values of 0.75 and 
1.15, respectively (Fig. 5.2). 
To satisfy the deployment criteria, the arteries with lightly and moderately calcified plaques 
underwent a second PTA. The additional PTA of the artery with moderately calcified plaque 
using a 5.5 mm balloon yielded a lumen diameter of 3.5 mm. On the other hand, even with a 
6 mm balloon, only a 3.0 mm lumen diameter could be reached for the artery with lightly 
calcified plaque, resulting in a partially successful balloon angioplasty. This can be attributed 
to the high amounts of stretch required to plastically deform the lightly calcified plaque.
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Table 5.2. The circumferential stresses (95th percentile) in the adventitial layer following the pressurization of the artery with a physiological blood 
pressure of 120 mmHg (Pre-Angio), balloon angioplasty and stent implantation for the arteries with lightly, moderately and heavily calcified plaques. 
 
 
 
 
Circumferential Stresses (kPa) (95th Percentile) 
Pre-Angio 
(@ 120 mmHg) 
Post 1st Balloon 
Angioplasty 
Post 2nd Balloon 
Angioplasty 
Post Stent Implantation 
Unconstrained Stent Diameter 
5 mm 6 mm 7 mm 9 mm 
Calcification        
Light 0.6 32 140 371 458 485 543 
Moderate 0.1 161 356 559 590 600 641 
Heavy 0.8 303 - 732 833 851 922 
 
Table 5.3. The minimum lumen diameter following the pressurization of the artery with a physiological blood pressure of 120 mmHg (Pre-Angio), 
balloon angioplasty and stent implantation for the arteries with lightly, moderately and heavily calcified plaques. 
 
Minimum Lumen Diameter (mm) 
Pre-Angio 
(@ 120 mmHg) 
Post 1st Balloon 
Angioplasty 
Post 2nd Balloon 
Angioplasty 
Post Stent Implantation 
Unconstrained Stent Diameter 
5 mm 6 mm 7 mm 9 mm 
Calcification        
Light 1.46 2.51 2.98 3.45 3.50 3.51 3.57 
Moderate 1.39 3.16 3.49 3.68 3.71 3.71 3.74 
Heavy 1.48 3.44 - 3.83 3.89 3.90 3.95 
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The PEEQ distributions in the atherosclerotic tissues following PTA support these observations 
(Fig. 5.4). Among the different plaque types, the heavily calcified plaque had the highest 
plastic strain not only at the lumen interface, but also along the thickness of the plaque after 
the initial balloon angioplasty (Fig. 5.4c). In line with the achieved lumen gains, the lightly 
calcified plaque exhibited the least amount of plastic strain within the complete 
atherosclerotic tissue (Fig. 5.4a) while the plastic strain in the moderately calcified plaque 
were in between the two groups (Fig. 5.4b). A 2nd PTA significantly affected the plastic strain 
distribution in the moderately calcified plaque. The procedure increased the overall plastic 
strain level and led to an increase in the volume that underwent plastic deformation (Fig. 
5.4e). Performing a 2nd PTA also had a similar effect on the distribution of plastic strain in the 
lightly calcified plaque (Fig. 5.4d). However, the overall plastic strain was still lower than the 
other plaque groups. 
 
Figure 5.4. The PEEQ distributions in the atherosclerotic tissues following the 1st PTA showed 
that the heavily calcified plaque had the largest plastic strain and, as such, the largest plastic 
deformation (c). The extent of plastic deformation was followed by the moderately calcified 
plaque (b) and, finally, the lightly calcified plaque (a). Performing a 2nd PTA resulted in a 
significant increase in the plastic strain level of the moderately calcified plaque (e). On the 
other hand, while the 2nd PTA also increased the extent of plastic deformation experienced by 
the lightly calcified plaque; the overall plastic strain was still lower than the other plaque types 
(d).   
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Following PTA, the arteries with heavily and moderately calcified plaques were in high stress 
states (Table 5.2). Additionally, they had similar stress values in the healthy layers surrounding 
the plaque. These can be attributed to the high levels of plastic strain observed in both plaque 
types. Comparatively, the stresses in the artery with lightly calcified plaque were significantly 
lower as its atherosclerotic tissue underwent a smaller plastic deformation than the other 
plaque types.  
The implantation of a Nitinol stent further increased the stresses and lumen diameters in all 
the artery models (Tables 5.2 & 5.3). However, compared to PTA, the procedure did not cause 
any additional plastic deformation. As a result, the additional stresses and lumen gains 
produced by stent implantation are directly influenced by the hyperelastic behavior, i.e. the 
mechanical stiffness, of the plaque, since the plaque tissue continued to support the loads 
exerted onto the artery following PTA. 
Regardless of the oversizing ratio, the artery with heavily calcified plaque always had the 
highest circumferential stresses and lumen diameter (Fig. 5.6). This can be attributed to the 
high stress-state of the artery following PTA and the low stiffness of the plaque (Fig. 5.2). On 
the other hand, while the lightly calcified plaque had a similar stiffness as the heavily calcified 
plaque, the artery always had the lowest circumferential stresses and lumen diameter. This 
low level of stress directly results from the low stress-state following balloon angioplasty. 
Stent implantation has led to a narrow distribution of the stresses in the arteries with lightly 
and moderately calcified plaques (Fig. 5.6). Again, this can be attributed to the low stiffness of 
the plaque tissues, allowing a uniform deformation and stress increase along the entire tissue. 
In contrast, the stress distribution in the artery with moderately calcified plaques was much 
wider, with lower minimum values than the stress levels observed in the arteries with lightly 
calcified plaques. This can be explained by the higher stiffness of the moderate plaque, acting 
as a stronger barrier that limits the amount of load transferred to the healthy tissues.  
For all plaque groups, increasing the oversizing ratio led to a linear increase in the 
circumferential stresses (Fig. 5.7). Similarly, a linear relationship was observed between the 
oversizing ratio and the lumen diameter (Fig. 5.7). The artery with heavily calcified plaque, 
followed by the artery with lightly calcified plaque, exhibited the largest increase in arterial 
stresses with increased oversizing. Correspondingly, these two plaque types had the largest 
increases in the acute lumen gains with oversizing. The similar behavior between these two 
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arterial models can be attributed to the similar stiffness of the lightly and heavily calcified 
plaques (Fig. 5.2). In comparison, the artery with moderately calcified plaque was the least 
affected in terms of arterial stresses and lumen gain due to the high stiffness of its plaque. 
 
Figure 5.5. The stress distribution in the artery with moderately calcified plaque following 
stent implantation showed that, regardless of the oversizing ratio, the most failure-prone 
layer was the healthy adventitia over the diseased region. Increasing the oversizing ratio led 
to an increase in the circumferential stresses of the artery, with the 9 mm stent (d) producing 
the highest stress, followed by the 7 mm stent (c), the 6 mm stent (b) and, finally, the 5 mm 
stent (a). 
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Figure 5.6. The stress distribution in the healthy adventitia has been reported for the different 
plaque types and oversizing ratios. Similar to the 95th percentile, the average stresses were 
lower for the artery with the lightly calcified plaque, followed by the arteries with moderately 
and heavily calcified plaques. The stress values in the adventitia showed a larger scattering for 
the artery with the moderately calcified plaque than for the other types of calcification. The 
wider distribution can be attributed to the plaque stiffness. Despite these differences, there 
was a linear relationship between the unconstrained stent diameters and the circumferential 
stresses (the 95th percentile, the 75th percentile, as well as the median values) for all the artery 
models.
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Figure 5.7. Regardless of the plaque type, Nitinol stent oversizing resulted in a linear increase 
in both the arterial circumferential stresses (left) and the lumen gains (right). For each 
oversizing ratio, the highest circumferential stresses were found to be in the artery with 
heavily calcified plaque, while the lowest were in the artery with lightly calcified plaque. On 
the other hand, the highest lumen gain was reported to be in the artery with lightly calcified 
plaque, followed by the arteries with heavily and moderately calcified plaques. In comparison, 
oversizing in a non-calcified artery resulted in a non-linear increase in arterial stresses, as well 
as in the lumen gain. Furthermore, diseased arteries were found to be less sensitive to 
oversizing than healthy arteries due to a smaller increase in the arterial stresses between each 
oversizing ratio. 
5.4. Discussion 
Nitinol stent oversizing is a term used to describe the ratio and, in extreme cases, the 
mismatch between healthy lumen and stent diameters.101,137 The procedure can occur either 
on purpose, by selecting a stent diameter that is larger than the healthy lumen diameter, or 
inadvertently, by implanting a single long stent over a considerably long lesion (>300 mm), 
which results in a mismatch between the constant stent diameter and the narrowing 
lumen.20,61 Currently, stent manufacturers provide a stent-specific value as the recommended 
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oversizing ratio. However, the bases for selecting these values are unclear. With no objective 
guidelines, clinicians either avoid oversizing and, as a result, do not utilize the procedure’s 
possible advantages (i.e. preventing stent migration, achieving a desirable lumen gain 
immediately after implantation etc.),93 or they tend to oversize the stents and risk arterial 
damage. More recently, animal studies and numerical analyses have been conducted to define 
an ideal oversizing ratio for the peripheral arteries.101,137 However, they were limited by the 
use of healthy arteries, whose morphologies are considerably different than diseased arteries. 
Thus, to understand the real-world implications of Nitinol stent oversizing, these studies 
should primarily be conducted on diseased arteries. Therefore, the aim of this study was to 
investigate the effects of Nitinol stent oversizing on the mechanical behavior of peripheral 
arteries by performing in-silico analyses of endovascular therapy in arterial models with a 
clinically relevant model of PAD. Furthermore, three different plaque types were considered 
in the model to evaluate whether the severity of plaque calcification has any influence on the 
treatment outcomes. The mechanical behavior of the artery during PTA is strongly affected by 
the plaque type. Between the lightly and moderately calcified plaques, the former had to 
undergo a comparatively higher stretch to reach its plastic limit (Fig. 5.2). On the other hand, 
the stress and strain values associated with the plasticity threshold of the heavily calcified 
artery was considerably lower than the other plaque types. These strain values (Table 5.1)26 
directly defined the configurations of the arteries following PTA. Thus, two of the artery types 
required a 2nd balloon angioplasty to achieve a satisfactory lumen diameter due to the high 
stretch that was necessary to start plastic deformation in their plaques. A 2nd PTA increased 
the amount of plastic strain in the moderately calcified plaque (Fig. 5.4d) to similar levels 
observed in the heavily calcified plaque after one PTA (Fig. 5.4c). This meant that both plaque 
types experienced similar amounts of plastic deformation, which can also be inferred from the 
similar lumen diameters and arterial stresses between the two artery types (Tables 5.2 & 5.3). 
For the lighly calcified artery, even a second PTA was insufficient to reach the level of strain 
needed to undergo the same level of plastic deformation as the other plaque types. As a result, 
the arteries with moderately and heavily calcified plaques were both in a higher stress state 
compared to the artery with lightly calcified plaque following PTA. 
The type of plaque also affected the outcomes following Nitinol stent implantation. Due to 
the use of perfect plasticity as a damage model, the deformed plaque continued to support 
the loads exerted onto the artery by the stent. However, unlike the situation during PTA, only 
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the hyper-elastic behavior of the plaque influenced the final configuration of the artery, as no 
additional plastic deformation was observed during stent deployment. As a result, the lumen 
gain obtained following stent implantation was considerably lower than the one achieved 
after PTA. The artery with heavily calcified plaque had a substantial increase in adventitial 
stresses following stent implantation due to its low mechanical stiffness in the elastic region 
(Table 5.2). Although being at a comparatively lower stress state after PTA, the artery with 
lightly calcified plaque also had a significant increase, which can be attributed to the similar 
mechanical stiffness of the two plaque types (Fig. 5.2). On the other hand, the artery with 
moderately calcified plaque had the least increase in adventitial stresses with stent 
implantation due to the higher stiffness of the moderate plaque. These outcomes were 
accordingly reflected in the lumen gains observed following stent deployment, with the 
arteries with heavily and lightly calcified plaques achieving a similar and higher lumen gain 
compared to the artery with moderately calcified plaque (Table 5.3) (Fig. 5.7). For all plaque 
types, the increases in adventitial stresses and acute lumen gains with respect to Nitinol stent 
oversizing were heavily dependent on the stent’s radial force profiles for different oversizing 
ratios (Fig. 5.3). A larger increase in the radial force of the stent has led to a correspondingly 
large increase in both arterial stresses and lumen diameters. As such, increasing the oversizing 
ratio from 1.0 to 1.2 (5 mm to 6 mm) or from 1.4 to 1.8 (7 mm to 9 mm) had a bigger effect 
on the mechanical response of the artery compared to the similar outcomes obtained with 
increasing the ratio from 1.2 to 1.4 (6 mm to 7 mm) (Tables 5.2 & 5.3). Despite this, the 
relationship between the arterial stresses (the 95th percentile, the 75th percentile and the 
median values) and the oversizing ratio, as well as the relation between the acute lumen gains 
and the unconstrained stent diameters, was found to be well approximated with a linear 
function for all plaque groups (Figs. 5.6 & 5.7). However, a mismatch between the increases 
in arterial stresses and lumen gain was also present with oversizing (i.e. 31% stress increase 
vs. 4% increase in the lumen gain when the oversizing ratio was increased from 1.0 to 1.8 for 
the artery with lightly calcified plaque).Comparison of the results with an oversizing study 
conducted in healthy peripheral arteries showed that the outcomes of the procedure differed 
significantly between the two artery types.45 Oversizing of healthy arteries led to nonlinear 
increases in both arterial stresses and lumen gains (Fig. 5.7). Furthermore, regardless of the 
plaque type, diseased arteries were less sensitive to oversizing, showcased by a smaller 
increase in adventitial stresses between each oversizing ratio. This can be explained by the 
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difference in the distribution of the loads between the healthy and diseased arteries. Whereas 
the adventitia primarily supported the majority of the mechanical load in the healthy artery; 
in the diseased arteries, the load was distributed between the plastically deformed plaque 
and the adventitia. 
Following stent implantation, the arteries with moderately and heavily calcified plaques 
exhibited higher stresses compared to the healthy artery. This result can be attributed to the 
revascularization of the artery with PTA. This procedure was only performed in the diseased 
arteries and determined the arterial stresses prior to stent deployment. By comparison, the 
stress levels in the arteries with moderately and heavily calcivited plaques after PTA 
corresponded to the stresses calculated in the healthy artery with an oversized stent of 5.5 
mm. At this stage, deploying a stent in the arteries with moderately and heavily calcified 
plaques further increased their high stress levels and ensured that their final stress states 
would be higher than the healthy artery. On the other hand, the artery with lightly calcified 
plaque was at a low stress state after PTA and the additional stresses produced by stents did 
not exceed the stress levels in the healthy arteries.  
In terms of lumen gain, the results suggested that the adventitia acted as a protective layer 
and prevented the artery from significant expansion in healthy arteries45,53. In the diseased 
arteries, however, the stent continued to push against the plaque, without producing any 
additional plastic deformation. As such, the resultant lumen gain was determined by the 
stiffness of the plaque tissue. Since the arteries with lightly and heavily calcified arteries had 
a low mechanical stiffness, they produced higher lumen gains than the non-calcified arteries. 
Despite these differences, the mismatch between the low lumen gain induced by stent 
oversizing and the large increase of the arterial stresses was also observed for the healthy 
arteries. 
Several assumptions had to be made within the current numerical framework. Within the 
diseased region, the intimal layer was replaced with the plaque tissue. However, since the 
adventitia becomes the mechanically predominant layer under high pressures (following 
PTA),110 the influence of the intimal layer on the mechanical behavior of the artery would be 
small and can be neglected. The artery was not pre-stressed, which may decrease the final 
values of the stresses observed after stent implantation. However, arterial pre-stressing 
would not affect the linear relation between the oversizing ratio and either the stresses or the 
lumen gain.  
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The model of perfect plasticity that is used for reconfiguring the plaque tissue represents a 
simplified approach to the failure of the calcified plaque. Although not exactly a failure model, 
perfect plasticity is commonly used to model plaque failure during endovacular 
therapy.19,22,23,32,92 The majority of these studies have set the stress threshold at 400 kPa19,22,23, 
which corresponded to an average value of plaque failure under uniaxial tensile tests.73 The 
remaining studies have used 270 kPa, which represented the rupture stress of a single 
atheresclerotic plaque.32,92 Conway et al. have justified using the ultimate tensile stresses as 
the plastic stress threshold by conducting a parametric study with different values.23 Their 
results showed that the variances in the stress threshold had a marginal effect on the 
mechanical behavior of the artery; changing the yield stress from 200 kPa to 400 kPa resulted 
in less than a 5% change in vessel recoil for all plaque types. Recently, Chiastra et al. have used 
the same methodology to simulate PTA and stent implantation in numerical models of 
coronary bifurcation.19 A combination of CT angiography and Optical Coherence Tomography 
(OCT) was used to validate the simulations. The results showed approximately 15%-20% error 
between the calculated shape of the artery and the experimental reconstruction based on the 
Hybrid OC-CT methodology. The results from both of these studies suggested that using failure 
stresses as a plastic threshold is a suitable approximation to model plaque failure.  
In any case, there is no information in the literature that suggests the plaque actually behaves 
the way it is modeled in this study during balloon angioplasty. Furthermore, with this model, 
the deformed plaque continues to support the loads that are exerted onto the artery by the 
stent, which may lead to an underestimation of the arterial stresses. Experimental and clinical 
studies that focus on understanding the failure behavior of the plaque should be undertaken 
to improve the existing knowledge and modeling of the failure characteristics of the 
atherosclerotic tissues. Finally, the results provide an overview of Nitinol stent oversizing 
based on a single stent design. Although we believe that the general behavior would be similar 
for other designs, the actual stress values and lumen diameters would likely be different.
5.5. Conclusion 
Despite Nitinol stent oversizing being routinely performed during endovascular interventions, 
the number of experimental and numerical studies that investigate the effects of the 
procedure has been limited. Furthermore, the studies have been performed almost 
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exclusively on healthy arterial models, completely overlooking the plaque tissue, the 
procedure of balloon angioplasty and the effect of the reconfigured calcification on the 
outcomes of stent deployment. Therefore, this study used calcified arterial models in order to 
give some insights on the implications of Nitinol stent oversizing in patients undergoing 
endovascular revascularizations. Both PTA and stent implantation were responsible for a 
significant increase in adventitial stresses. However, PTA alone was the primary force behind 
achieving a substantial lumen gain. Among the different plaque types, oversizing seems not 
be critical for the lightly and moderately calcified arteries; due to the former being at a lower 
stress state and the latter having the least increase in adventitial stresses with oversizing. 
However, for both cases, the procedure only produces a marginal lumen gain. For the heavily 
calcified arteries, oversizing should be avoided as it only acts to increase an already high stress 
state following PTA towards the failure limit of adventitia.52 These results further support the 
notion that stents are inherently made to act as scaffolds and not as instruments to facilitate 
additional lumen expansion.
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Chapter 6 
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The main objectives of this thesis were to characterize the deformation behavior and 
mechanical response of the femoro-popliteal (FP) arterial tract through clinical and numerical 
investigations. The motivation behind the clinical part of the thesis was based on the high 
restenosis rates that continue to negatively affect the long-term outcomes of endovascular 
procedures in the lower-limb arteries.27,58,115 Based on the limitations in the literature, there 
was a clear need to improve the existing knowledge of the complex deformations the FP artery 
undergoes during routine activities, such as walking and stair-climbing.16,40,63,87 Although there 
has been a specific focus on FP artery deformations for the last two decades, previous works 
were mainly conducted on subjects that did not represent the population targeted for 
endovascular therapy.16,17,62 As such, utilizing these results to improve current implantation 
procedures and stent designs would be erroneous. On the other hand, the low number of 
works that included patients with Peripheral Arterial Disease (PAD) had methodological 
limitations that, at best, can lead to incorrect interpretations of the reported outcomes and, 
at worst, can affect the accuracy of their results.40,87 Currently, there are no works that show 
the effects endovascular therapy has on the deformation behaviors of the PAD-afflicted FP 
arteries by comparing the pre- and post-intervention deformations on the same patients. 
Furthermore, none of the studies have made comparisons between the effects of different 
endovascular procedures (i.e. Percutaneous Transluminal Angioplasty (PTA) vs. Nitinol stent 
implantation) on arterial deformations, which may be used to inform about possible 
improvements to existing stent designs. Therefore, the clinical part of the study was designed 
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to investigate the effects of PAD, PTA and stent implantation on the deformations of the FP 
arteries during leg flexion.  
Initially, a pilot study was performed on five patients with PAD using 3D rotational 
angiography.44 The data revealed that, not unlike the healthy FP arteries, the diseased 
popliteal arteries undergo significant shortening and twisting, and experience a notable 
increase in their curvature profiles with leg flexion. Additionally, the change in the curvature 
was found to be directly affected by the extent of arterial calcification. This study showed that 
3D rotational angiography is able to fully characterize the FP arterial deformations. However, 
the imaging modality is time consuming and induces additional radiation to the patients.  
Therefore, a technique that is able to provide an accurate reconstruction of a 3D model of the 
FP artery based on multiple 2D angiographic images was developed.112 This approach has the 
benefit of allowing more freedom concerning the type of leg flexion that the patient can 
perform and it could be easily integrated to the clinical workflow. Based on this method, the 
arterial deformations of 35 patients, diagnosed with PAD, were quantified prior to 
endovascular therapy and following either PTA or primary Nitinol stent placement.46 Through 
direct comparisons with the pre-angioplasty measurements, the results showed that the 
choice of the treatment method substantially affects the post-interventional axial 
deformations of the FP arteries. Performing only PTA produced a more flexible artery, while 
the implantation of a stent further restricted the arteries’ shortening capabilities.  
The arterial deformations obtained from the clinical studies provide greater insight into the 
mechanical environment of the diseased FP arteries and how they are affected by the 
available endovascular procedures currently being employed to treat PAD. The major 
significance of these studies lies in their utilization to improve existing stent designs. Three 
different stents were found to impact the natural shortening behavior of the artery during leg 
flexion. This information can directly be used to reevaluate the performance of other stents 
that are placed in the FP arteries and additional modifications can be made to replicate the 
effects of performing PTA. The deformations can easily be adapted to be used in in-vitro 
studies to investigate the commercially available stents’ fatigue behaviors. Instead of applying 
generic forces to replicate the in-vivo conditions, these deformations would give a more 
accurate description of the arterial deformations that the stents would actually undergo once 
they are implanted in the PAD-afflicted arteries. Similarly, the deformations can easily be used 
in numerical analyses that aim to investigate the mechanical behaviors of the arteries and 
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stents, as well as stent-artery interactions, during leg flexion. Although some of the numerical 
studies use clinical images to generate accurate models of the legs, the contact interactions 
and boundary conditions they adopt to simulate leg flexion have no clinical basis (simple 
boundary conditions, the absence of a stent model, no validation).31,36,49,85,86,96 By combining  
the 3D reconstructed shapes of each artery with their corresponding deformations, patient-
specific numerical models, which can support the clinical outcomes and present results 
unobtainable through conventional means, can be generated and validated. This information 
can be used to improve the understanding of the surgeon on each of his patients to help him 
adapt the treatment strategy for the specific situation. In the future, this information can lead 
to predictive models and optimize the surgery based on numerical tools. Additionally, these 
patient-specific models could be used to optimize stent designs, select correct stent lengths 
and placement to minimize the risk of restenosis. 
The motivation behind the numerical part of the thesis was mainly based on the contradictory 
outcomes between the animal and clinical studies concerning Nitinol stent 
oversizing.61,93,101,137 Furthermore, the studies that focused on the FP arterial segment only 
investigated the responses of the healthy arteries to this controversial procedure and none of 
the studies were supported with numerical analyses. To date, the implications from these 
studies were being used to derive conclusions on the procedure’s effects on diseased arteries, 
and the actual mechanical behavior of the PAD-afflicted arteries under Nitinol stent oversizing 
was not known. Therefore, a validated FE framework was generated, healthy FP arteries with 
patient-specific geometries and idealized arteries with clinically relevant levels of PAD. Based 
on the artery model, either only stent implantation or the complete endovascular therapy 
(PTA + stent implantation) was simulated. The analyses provided important observations 
concerning Nitinol stent oversizing in FP arteries. Regardless of the presence of a plaque 
tissue, results showed that Nitinol stent oversizing was found to produce a marginal lumen 
gain in contrast to a significant increase in arterial stresses. For the lightly and moderately 
calcified arteries, oversizing was found to be non-critical; whereas for healthy and heavily 
calcified arteries, the procedure should be avoided due to a risk of tissue failure. These 
adverse effects to both the artery walls and stents may create circumstances for restenosis. 
Although the ideal oversizing ratio is stent-specific, the studies showed that Nitinol stent 
oversizing has a very small impact on the immediate lumen gain, which contradicts the clinical 
motivations of the procedure.  
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The major limitation of the numerical framework concerns the mechanical behavior of the 
plaque under PTA. Although endovascular treatment of the FP arteries has been the subject 
of numerous numerical studies, the parameters corresponding to this step of the procedure 
are generalized and based on assumptions.19,32 Clinically, balloon angioplasty is expected to 
“crack” the lesion, and redistribute the diseased material along the arterial walls. However, 
the process behind this “cracking”, as well as the final anatomical configuration of the residual 
stenosis, remains unclear, resulting in numerical models that are based on qualitative 
information from angiographic images and clinicians. In addition, the mechanical process 
resulting in the permanent deformation of the lesions is mostly unknown. Several mechanisms 
have been proposed such as elasto-plastic deformation or stress softening.22,26 Up to now, 
among the limited number of experimental studies conducted on the atherosclerotic femoral 
plaques, none of the experimental findings could be used to determine the most appropriate 
approach.25 This information is crucial to having an accurate model of the PTA and the 
subsequent step of stent implantation. A possible approach to understand and implement this 
behavior within the numerical framework would be to perform Intravascular Ultrasound 
(IVUS) or Optical Coherence Tomography (OCT) imaging. By taking IVUS or OCT-images prior 
to and following PTA, the changes in the anatomy of the lesion could be quantified. The direct 
and accurate reconstruction of the shape of the tissue after balloon angioplasty will help 
address open questions concerning the mechanism of re-vascularization, will provide a 
validation step for the numerical analyses, as well as an accurate representation of the 
anatomical configuration before stent placement. 
The current hypothesis suggests that the restenosis in FP arteries following stent implantation 
is mainly associated with adverse changes in the deformation behavior and mechanical 
response of the artery due to the introduction of a device that disrupts the artery’s natural 
deformations during leg movement. We believe that the natural extension of this hypothesis 
is the prediction of restenosis through specific mechanical markers derived from patient-
specific numerical models, which require precise information on the anatomy, mechanical 
properties and boundary conditions. As shown in this thesis, the boundary conditions that are 
needed to simulate leg flexion can be acquired through in-vivo measurements using 2D X-ray 
angiography. The rest, however, cannot be readily obtained; i.e. the imaging modalities used 
in this thesis only allow for the reconstruction of patient-specific curvatures. As such, 
additional imaging technologies, such as OCT, is necessary to reconstruct the lumen of the 
Chapter 6. Conclusion & Outlook | 93 
 
 
  
artery, and determine the thickness, type and composition of the lesions. Furthermore, OCT 
images acquired following stent implantation can be used to validate the results of the 
numerical analyses.  An in-vivo characterization of the material properties of the artery, in the 
form of compliance measurements, can be performed using IVUS. The combination of these 
different imaging methodologies with consistent follow-up studies and a numerical 
framework, similar to the one introduced in the 2nd part of this thesis, can provide an overall 
structure to determine the relationship between the mechanical markers (such as stent wall 
apposition, level of arterial damage, un-physiological arterial deformations, stress and strain 
distributions) and restenosis.  
The techniques described here will hopefully help clinical practice by improved understanding 
of the basic biomechanical properties of the commonly involved FP arteries. In addition, the 
expected outcomes will provide novel information required to design enhanced stents and 
improved placement strategies into the arteries. Ultimately, insights from the present 
research protocol may help predict and prevent possible cases of in-stent restenosis at the 
baseline based on post-treatment arterial deformations, improve long-term outcomes for 
patients that have undergone PAD treatment and reduce the need for repeated 
revascularization procedures, thereby providing relief for healthcare systems.
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